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ABSTRACT 
Sex differences in response to noxious stimuli and in the development of chronic pain have been 
increasingly recognized and studied in humans and laboratory animals. In the clinic, extensive evidence 
indicates that there are a large number of chronic pain conditions that have higher prevalence in women 
than in men and some of these conditions, such as migraine and temporomandibular pain disorder, are also 
affected by the menstrual cycle. The mechanisms for sex differences in pain, particular in chronic pain, are 
largely unknown. The work presented in this thesis aims to explore mechanisms of sex differences using 
experimental pain models in rodents. 
 
In the first part of the thesis, we explored the role of estrogen receptors and the adenosine A2A receptor in 
sex differences in pain using genetically modified mice. We observed that in wild-type controls for 
estrogen receptor α or β knock-outs, females were significantly more sensitive than males to mechanical 
stimulation under normal condition and after carrageenan-induced inflammation. Such sex differences 
were eliminated in mice lacking either estrogen receptor α or β. Mechanical hypersensitivity resulting from 
partial sciatic nerve injury did not however differ between the sexes or between the wild-types and both 
estrogen receptor knock-outs. These results suggest that estrogen receptors α or β play a role in sex 
difference in basal mechanical pain threshold and inammatory hypersensitivity. There was no sex 
difference in baseline mechanosensitivity in mice lacking the adenosine A2A receptor and wild-type 
controls. Carrageenan-induced mechanical hypersensitivity was significantly reduced in the A2A receptor 
knock-outs compared to wild-types. ZM-241,385, a selective A2A receptor antagonist, reduced 
inflammatory hypersensitivity in wild-type females, but not in males. The selective A2A receptor agonist 
CGS 21680 produced significantly more hypersensitivity in wild-type female mice than in males. These 
results suggest that activation of peripheral adenosine A2A receptors contributes to inflammatory 
hypersensitivity and that this effect is more prominent in females than in males. 
 
The second part of the thesis deals with the development of neuropathic pain-like behaviors (allodynia) in 
rats after spinal cord or infraorbital nerve injury. We observed a significant sex difference (females > 
males) in the development of mechanical allodynia after spinal cord injury in rats independent of the 
extent of injury. Increased mechanical hypersensitivity in females was not related to estrous stage at the 
time of injury. Similarly, after infraorbital nerve injury, female rats developed more persistent local and 
spread mechanical allodynia which was also not influenced by the estrous stages at the time or after injury. 
 
These studies provide further evidence for the presence of sex difference in baseline mechanical pain 
threshold, inflammatory hypersensitivity and experimental neuropathic pain in rodents. Furthermore, our 
results showed that estrogen receptors and adenosine A2A receptor may be involved in sex difference in 
pain sensitivity under normal condition or after inflammation. Finally, although female rats developed 
more persistent allodynia-like behaviors after spinal cord or infraorbital nerve injury, there appears to be 
no impact of the estrous cycle on pain development. 
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1 INTRODUCTION 
 
1.1 PAIN: DEFINITION AND CLASSIFICATION 
 
Pain normally serves as an alarm system activated in response to impending damage to 
the organism. According to the International Association for the Study of Pain (IASP), 
pain is an unpleasant sensory and emotional experience associated with actual or potential 
tissue damage (Merskey and Bogduk, 1994). It is a multidimensional experience, which 
contains essentially a sensory, cognitive and emotional component (Woolf, 2004).  
 
Pain can be classified into different categories according to various criteria, such as those 
based on the cause of pain, its duration, location, underlying diseases etc. The most 
widely used criteria are aetiological (i.e. based on the cause of pain). In this regard, pain 
can be classified into three major categories, nociceptive, inflammatory and neuropathic. 
Nociceptive pain is generated by activation of nociceptors that are specialized to be 
activated by noxious stimuli which have the potential of causing tissue damage. 
Nociception or nociceptive pain is essential in survival for organisms to avoid potential or 
actual tissue damage (Scholz and Woolf, 2002). Nociceptive pain is mostly recognized as 
acute pain since that pain stops when the stimulus has been removed. 
 
Inflammatory pain is associated with processes that can be caused by tissue damage, 
infections, tumor growth and various forms of chronic inflammatory diseases, such as 
autoimmune disease. During inflammation, multiple mediators are released locally from 
the damaged and recruited inflammatory cells. This results in the release of cytokines, 
growth factors, neuropeptides, kinins, purines, amines, prostanoids and ions, including 
protons (Boddeke, 2001; Manthy et al, 2002). These mediators can activate and sensitize 
nociceptors, thus evoke pain (Scholz and Woolf, 2002). The symptoms of inflammation 
include cell migration, oedema, erythema, pain and hyperalgesia (Marchand et al, 2005). 
In most of the cases, inflammatory pain responds to non-steroid anti-inflammatory drugs 
(NASIDs) or opiates such as morphine (Basbaum et al, 2008; Fitzcharles et al, 2010). 
Inflammatory pain under many conditions such as rheumatoid arthritis (RA) is chronic. 
Chronic inflammatory pain can be characterized by hyperalgesia (greater pain after 
normally painful stimuli) and allodynia (normally non-noxious stimuli that are perceived 
as painful). 
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Neuropathic pain arises from a primary lesion or dysfunction in the peripheral or central 
nervous system (CNS) (Merskey and Bogduk, 1994). Examples of neuropathic pain 
include painful polyneuropathy, postherpetic neuralgia, trigeminal neuralgia, spinal cord 
injury pain and post-stroke pain. Clinically, neuropathic pain is characterized by 
spontaneous ongoing or shooting pain and evoked pain such as hyperalgesia and allodynia 
(Baron et al, 2010). Neuropathic pain is mostly chronic, difficult to treat and associated 
with plasticity in the central and peripheral nervous system. The mechanisms of 
neuropathic pain are not well understood and treatments are largely unsatisfactory. 
Neuropathic pain may respond to some antiepileptics, tricyclic antidepressants, and 
antiarrhythmics. Local anesthetics used to block the nerve may also be effective in some 
cases. 
 
1.2 PAIN PATHWAYS 
 
Nociception is initiated when noxious stimuli, which may be mechanical, thermal or 
chemical, are detected by nociceptors (Basbaum and Jessell, 2000). The cell bodies of the 
nociceptors are located in the dorsal root ganglion (DRG) and the trigeminal ganglions 
and they have peripheral and central axons that innervate their target organ and the spinal 
cord, respectively (Basbaum et al, 2009). There are two major categories of nociceptors, 
Aδ fibers and C fibers (Meyer et al, 2008). Aδ fibers are thinly myelinated and respond to 
mechanical and thermal stimulation. These fibers differ considerably from larger diameter 
Aβ fibers which respond to innocuous mechanical stimulation (i.e., light touch). C fibers 
are unmyelinated, and many of them are polymodal which means that they respond to 
stimulation of different modalities such as heat, mechanical stimuli, protons and cold 
(D’Mello and Dickenson, 2008). The energy of noxious stimuli is converted into 
electrical activity by these receptors and conducted to the spinal cord where the central 
axons of sensory nerves terminate (Scholz and Woolf, 2002). 
 
The dorsal horn of the spinal cord is the receiving zone for primary afferent axons that 
transmit signals from nociceptors. In general, Aδ fibers and C fibers terminate in the 
superficial layers, laminae I and II, although some reach deeper laminae (Light and Perl, 
1979; Sugiura et al, 1987).  Large myelinated fibers including Aα and Aβ fibers project to 
the deeper laminae (laminae III-VI) (Brown, 1981). A large number of neurons located in 
the dorsal horn are capable of responding to input from primary afferents. Among these 
are nociceptive specific neurons located primarily in lamina I of dorsal horn which 
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respond exclusive to activation of nociceptors, and wide dynamic range (WDR) neurons 
(Kandel and Schwartz, 1991), located mostly in the deeper laminae of the dorsal horn. 
WDR neurons respond to stimulation of various sensory modalities (thermal, chemical 
and mechanical) and in a graded fashion in accordance to the intensity of stimulation 
(Cervero et al, 1976). 
 
From the spinal cord, the nociceptive information is conveyed to the thalamus via the 
contralateral spinothalamic tract, to the medulla and brainstem via the spinorecticular and 
spinomesencephalic tracts or to the hypothalamic nuclei via the spinohypothalamic tract. 
Ascending information is further transmitted to several cortical and subcortical brain 
regions including anterior cingulate cortex, insular cortex, frontal and pre-frontal cortices, 
primary and secondary somatosensory cortices, and amygdala (Tracey, 2005). Brain 
structures such as periaqueductal gray (PAG) and the nucleus raphe magnus (NRM) also 
modulate pain transduction by either inhibiting or facilitating spinal nociceptive input 
(Porreca et al, 2002). 
 
1.3 SEX DIFFERENCES IN PAIN AND THE ROLE OF SEX HORMONES 
 
As a complex and multidimensional sensory experience, pain responses of different 
individuals can be affected by a broad range of variables, such as genetic, physiological, 
psychological, cultural and social factors (Holdcroft and Berkley, 2005; Greenspan et al, 
2007). In recent years, sex has been shown to be an important factor in modulating the 
experience of pain with a growing body of evidence demonstrating that males and 
females experience pain differently and respond differentially to specific classes of 
analgesics (Paller et al, 2009). In both experimental and clinical studies, pain thresholds 
and pain tolerance are generally shown to be lower in females than males as tested with 
various stimulus modalities (Berkley, 1997; Fillingim et al, 1999; Mogil, 2000; Barrett et 
al, 2002; Wiesenfeld-Hallin, 2005; Greenspan et al, 2007). Females report also more 
frequent, severe and longer lasting pain which is often anatomically more diffused than 
males with similar disease processes (Berkley, 1997; Hurley and Adams, 2008). There are 
many chronic pain states such as migraine, temporomandibular disorder (TMD), 
rheumatoid arthritis (RA), irritable bowel syndrome (IBS), and fibromyalgia that are more 
prevalent in women (Ektor-Andersen et al, 1993; Craft et al, 2004; Holdcroft and Berkley, 
2005; Greenspan et al, 2007). However, some chronic conditions such as migraine 
without aura and cluster headache are more common in men (Greenspan et al, 2007). 
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Imaging studies of the brain have shown sex differences in humans in the intensity of 
cerebral activation and the spatial pattern in response to acute noxious stimuli (Paulson et 
al, 1998; Derbyshire et al, 2002; Zubieta et al, 2002; Moulton et al, 2006).  
 
The response to analgesics has also been shown to be sex dependent (Craft, 2003; 
Wiesenfeld-Hallin, 2005; Berkley et al, 2006). In humans, women have greater response 
to µ-opioid agonists than men (Kest et al, 2000; Cook et al, 2000; Craft, 2003) whereas in 
rodents, morphine appears to be more effective in males than in females (Mogil et al, 
2000; Berkley et al, 2006). The response to κ-opioids is also different between sexes in 
both mice and human (Wiesenfeld-Hallin, 2005). κ-Receptor  agonists  appear to be more 
potent analgesics in women than in men (Gear et al, 1996 and 1999) which may be due to 
pain modulation by the  melanocortin-1 receptor  (Mclr) gene in a female-specific manner 
in both mice and human (Mogil et al, 2003). Besides opioids, responses to other 
analgesics also show sex differences. For example, administration of an inammatory 
agent to cyclooxygenase-1(COX-1) and cyclooxygenase-2 (COX-2) knock-out mice had 
greater effects in females (Chillingworth et al, 2006). Similarly, Chanda and Mogil (2006) 
found that a non-specic analgesics-acid-sensing ion channel (ASIC) blocker (amiloride) 
had greater analgesic effect in female mice on formalin-induced nociception. 
 
Sex hormones (androgens, estrogens and progestagens) have received considerable 
attention in research of the mechanisms of sex differences in pain. The levels of plasma 
estrogen vary throughout the menstrual cycle during the reproductive years (18-50 years) 
(Fig.1a) and they are on average 3–10 times greater than those found in men (Eldrup et al, 
1987). It has been shown that in many chronic pain conditions, there is a correlation 
between pain and the menstrual cycle. For example, about 10% of female migraine 
sufferers have menstrual migraines, whereas headaches regularly occur at the beginning 
of menstruation (Brandes, 2006; Martin and Lipton, 2008). The highest severity of TMD 
pain was noted during the late luteal and early follicular phases. There was also a second 
peak of increased pain severity that occurred around ovulation in normally cycling 
women (LeResche et al, 2003). Menopause, which results in a decrease in estrogen levels 
in women, is strongly associated with changes in musculoskeletal pain conditions. The 
number of women with RA and fibromyalgia increases around menopause, whereas the 
number of women suffering from migraine and TMD decreases (Pamuk and Cakir, 2005; 
Greenspan et al, 2007; Cairns and Gazerani, 2009). A number of studies have also 
examined changes in pain in response to noxious stimuli across the menstrual cycle in 
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human. A meta-analysis of these studies indicates that for most forms of painful stimuli 
(with exception of electrical stimuli), higher pain thresholds and tolerance are observed 
during late follicular and luteal phases, and the effect size is small to moderate (Riley et 
al, 1999).  
 
The female rat has a 4-5 day vaginal estrous cycle which is correlated with changes of 
hormone levels (Fig.1b). The estrous cycle in rats is generally divided into 3 stages: 
proestrous, estrous and diestrous (Krinke, 2000). In cycling females, serum estradiol 
concentration is low during estrous, gradually rises during diestrous, peaks during early 
proestrous, and declines during late proestrous. Serum progesterone concentration peaks 
twice, once during middle diestrous and a second time during late proestrous (Butcher et 
al, 1974). There is evidence to suggest that baseline pain sensitivity in rats peaks during 
proestrous and early estrous compared to diestrous (Fillingim and Ness, 2000). Hind paw 
withdrawal latencies were significantly higher during proestrous than during estrous and 
diestrous in carrageenan-infammed rats (Tall and Crisp, 2004).  In a TMD model of pain, 
it was reported that females in proestrous exhibited fewer pain behaviors than those in 
diestrous (Clemente et al, 2004). Modulation of opioid-mediated analgesia by menstrual 
cycle has also been reported. Opioids are shown to be less potent during estrous compared 
to females tested in other stages (Craft et al, 2004). There is also some evidence that 
opioid potency differs between rats tested in ´´early´´ vs ´´late´´ proestrous (Berglund and 
Simpkins, 1988; Stoffel et al, 2003). Taken together, sex differences and the effect by 
menstrual cycle suggest that the sex hormones of females may affect behavioral responses 
to pain. Although the exact mechanisms by which sex hormones affect pain sensitivity, 
especially in chronic pain conditions, has not been determined.  
 
Fig.1 Fluctuation of estradiol, progesterone, and luteinizing hormone (LH) in humans (a) 
and rats (b) during the menstrual and estrous cycle, respectively (Greenspan et al, 2007).  
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Generally, the impacts of gonadal steroid hormones fall into two categories, 
organizational or activational (Cooke et al, 1998). Organizational effects of hormones 
result in permanent structural and functional differences in the CNS during development. 
Activational effects are temporary and reversible and result from steroid activation or 
inhibition on existing circuits in the adult often through specific receptors. That is, 
hormones continue to promote male or female characteristics in the adult by acting on 
neural circuits that were organized during development (Aloisi et al, 2006). Animal 
studies showed that sex differences in pain can often be eliminated by manipulating 
gonadal hormones during neonatal periods or adulthood. For example, male rodents are 
more sensitive than females to morphine-induced analgesia (Mogil et al, 2000), whereas 
neonatally castrated males are less sensitive to morphine than normal males, and in 
contrast, neonatally androgenized females are more sensitive to morphine than normal 
females (Cicero et al, 2002;  Krzanowska et al, 2002). Gonadectomized male pups 
exhibited greater mechanical allodynia in carrageenan-induced inflammation and 
testosterone replacement cannot reverse this phenomenon (Borzan and Fuchs, 2006). 
LaCroix-Fralish et al. (2005a) demonstrated that female rats developed more hyperalgesia 
after lumbar nerve injury, whereas the enhanced hypersensitivity in females was reversed 
in pubertal and adult animals ovariectomized 6 weeks prior to the injury.  
 
1.4 ROLE OF ESTROGEN AND ITS RECEPTORS IN PAIN 
 
In women, rapid decreases in estrogen level at menstruation appear to further increase 
ongoing muscle and joint pain in TMD and RA as well as in migraine (LeResche et al, 
1997; Brandes, 2006). Estrogens are produced primarily in the ovaries during 
reproductive years (Craft et al, 2004). There are three major natural estrogens in women: 
estradiol, estrone, and estroil. Estradiol is the predominant form in nonpregnant females 
whereas estrone is produced during menopause and estriol is the primary estrogen during 
pregnancy (Ascenzi et al, 2006). In the body estrogens are produced from androgens 
through aromatization by enzymes. Small amounts of estrogens are also produced by 
other tissues such as the liver, adrenal glands, and the breasts. These secondary sources of 
estrogens are especially important in postmenopausal women (Nelson and Bulun, 2001).  
 
Estrodiol is highly lipophylic and therefore can pass the blood–brain barrier and cell 
membranes. Two types of receptors for estrogen (ERs) have been identified and are 
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named ER-alpha (ERα) and ER-beta (ERβ). They are intracellular receptors and located 
in the nucleus (Gruber et al, 2002; Koehler et al, 2005). These receptors are the main 
mediators of estrogen’s effects (Mueller and Korach, 2001). Some estrogen receptors 
associate with the cell surface membrane and can be rapidly activated by exposure to 
estrogen (Levin, 2009), but how much this pathway interacts with pain modulation is not 
clear (Craft, 2007). Estradiol binds equally well to both receptors with high affinity, 
estrone and estriol bind preferentially to the ERα and ERβ, respectively (Fan et al, 2010). 
It is generally believed that estrogens diffuse into the cell and bind to the ERs homo- 
or hetero-dimers to act as transcription factors. Then, this nuclear estrogen-ER complex 
binds to estrogen response element (ERE) sequences directly or indirectly through 
protein-protein interactions with activator protein 1 (AP1) site in the promoter 
region of estrogen-responsive genes, resulting in changes in mRNA levels and 
protein production and finally, physiological response (Deroo and Korach, 2006).   
 
ERα and ERβ are both present in the DRGs, spinal cord (laminae I and II), trigeminal 
subnucleus caudalis as well as hypothalamus, amygdala, PAG and dorsal raphe nucleus, 
areas involved in pain transmission and modulation (Shugrue et al, 1997). ERα and ERβ 
are differentially regulated in different tissues, including in the CNS (Osterlund et al, 
1998) and DRGs (Taleghany et al, 1999). By action on ERα and ERβ, estrodiol modulates 
nerve growth factor (NGF) receptor in DRGs, endogenous enkephaline expression (Priest 
et al, 1995) and µ-opioid receptor levels (Amandusson et al, 1996 and 1999; Micevych et 
al, 1997; Quiñones-Jenab et al, 1997; Micevych and Sinchak, 2001). Animal studies 
showed that increased formalin-induced paw licking after central administration of 
estrodial (Aloisi and Ceccarelli, 2000). Estrodial also has been reported to increase pain 
response after peripheral or spinal cord injury (Gorman et al, 2001; Dina et al, 2007). By 
large, the role of ERα and ERβ in pain and sex difference in pain has not been thoroughly 
studied. 
 
1.5 ADENOSINE AND ADENOSINE RECEPTORS IN PAIN 
 
Adenosine is an endogenous nucleoside and a structural component of nucleic acids such 
as adenosine triphosphate (ATP), adenosine diphosphate (ADP) and cyclic adenosine 
monophosphate (cAMP) (Fig. 2A). It is a ubiquitous homeostatic substance released from 
most cells, including neurons and glia under normal conditions or under depolarization, 
such as during elevated K+ concentrations, electrical stimulation and glutamate receptor 
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activation. Adenosine is involved in many biological processes such as energy transfer 
and signal transduction and also physiological processes such as cardiovascular 
regulation, cognition, and neuroprotection (Fredholm, 1997; Ribeiro et al, 2002). 
            
    
                    A                          B 
 
Fig. 2 Structure of adenosine (A) and adenosine receptor coupling (B). 
 
There are at least four subtypes of G-protein coupled receptors, adenosine A1, A2A, A2B 
and A3 (A1R, A2AR, A2BR, A3R) (Fredholm et al, 2001). A1Rs are usually coupled to 
inhibitory Gi or Go G-proteins (Linden, 2001). A2ARs and A2BRs are coupled to Gs G-
protein. A3Rs are coupled to Gi, Gq, and Go-protein (Fredholm et al, 2001; Ribeiro et al, 
2002). A2AR raises cAMP and A1R decreases cAMP, hyperpolarizes neurons and 
depresses calcium currents (Dolphin et al, 1986; Dunwiddie and Masino, 2001; Fredholm 
et al, 2001). A1R is widely distributed in brain, spinal cord and the periphery (Fredholm et 
al, 2001), whereas adenosine A2ARs are predominantly expressed in basal ganglia, in the 
periphery and in immune cells (Dunwiddie and Masino, 2001).  
 
Adenosine has complex effects on nociceptive pathways and can either enhance or 
decrease nociception, depending on the site of administration and the receptor subtype 
activated (Sawynok, 1998; Sawynok and Liu, 2003) (Fig. 2B). Activation of A1R, located 
primarily interneurons in the inner lamina II of the superficial dorsal horn (Schulte et al, 
2003), primarily produces inhibition of neuronal activity in the spinal cord and DRGs 
(Dolphin et al, 1986; Li and Peril, 1994; Reeve and Dickenson, 1995; Deuchars et al, 
2001) and administration of adenosine agonists that activate A1Rs produces 
antinociception in a variety of tests (Sawynok and Liu, 2003). Mice lacking the A1R have 
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an enhanced response to nociceptive stimuli under normal conditions, after inflammation 
and nerve injury (Johansson et al, 2001; Wu et al, 2005) supporting an inhibitory function 
for A1Rs in nociception. 
 
The role of A2ARs in peripheral and spinal nociception is less clear than that of A1Rs. The 
A2AR gene is expressed in the DRG and in the peripheral and central presynaptic 
terminals of sensory afferents in rats (Kaelin-Lang et al, 1998), suggesting the potential 
involvement of A2AR in pain. A2AR knock-out (A2AR-/-) mice are hypoalgesic in tests of 
acute nociception (Ledent et al, 1997) and the selective A2AR antagonist SCH 58261 
attenuates nociceptive responses in acute pain tests and in the formalin test in mice, 
suggesting a pronociceptive role of A2ARs (Godfrey et al, 2006; Hussey et al, 2007). In 
contrast, CGS 21680, a selective A2AR agonist, has also been shown to produce 
antinociception upon intrathecal administration in the formalin test and after inflammation 
(Poon and Sawynok, 1998; Yoon et al, 2005).  
 
Sex difference in adenosine modulation of physiological functions has also been reported. 
For example, the magnitude of the involvement of the A1Rs in regulation of heart rate, 
body temperature and locomotor activity in mice is different in males and females as 
studied in knock-out mice (Yang et al, 2007). The neurotoxic effects of A1R antagonism 
during ethanol withdrawal also exhibit sex difference (Bulter et al, 2008 and 2009) as 
does the incidence of chest pain during adenosine infusion in human cardiac patients 
(Kumar and Movahed, 2002). However, the role of A2AR in sex difference in pain has not 
been examined. 
 
1.6 ANIMAL PAIN MODELS AND GENETICALLY MODIFIED MICE 
 
Animal models for pain can be roughly categorized into three groups, tests of nociception, 
models of acute pain and chronic pain. The nociceptive pain tests evaluate the response of 
animals to nociceptive stimuli using for example the hot plate, tail flick or paw pressure 
tests. Acute pain models include cutaneous inflammation (carrageenan or Freund’s 
adjuvant), monoarthritis (carrageenan, kaolin), traumatic injury (skin incision, bone 
fracture) and some models of visceral pain (Ness and Gebhart, 1988). There are also 
animal models for chronic pain, including models for cancer pain, polyarthritis and 
neuropathic pain. In recent years, a large number of neuropathic pain models have been 
developed after various injuries to the peripheral or central nervous system. The rat sciatic 
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nerve as well as its branches has been used most often for the study of peripheral 
neuropathy because they innervate the hind paw, which is a suitable site for sensory 
testing (Bennett and Xie, 1988; Seltzer et al, 1990; Kim and Chung, 1992; Hogan, 2002). 
Models using other forms of injury (such as ischemia, toxin or viral infection) or affecting 
other peripheral nerves (such as infraorbital nerve innervating facial region) have also 
been developed (Xu and Wiesenfels-Hallin, 2003). There are also central neuropathic 
pain models, mostly after injury to the spinal cord using the photochemically-induced 
ischemia technique (Hao et al, 1991), compression (Martin et al, 1992; von Euler et al, 
1997), weight drop (Siddall et al, 1995), and surgical hemisection (Christensen et al, 
1996).  
 
In the current work, several pain tests and models were used. These include nociceptive 
tests, carrageenan-induced acute inflammation, photochemically-induced sciatic nerve 
injury (Hao et al, 2000), infraorbital nerve injury (Dominguez et al, 2009) and spinal cord 
injury models (Xu et al, 1992).  
 
Transgenic knock-out mice have been widely employed in pain research (Lariviere et al, 
2001; Malmberg and Zeitz, 2004; LaCroix-Fralish and Mogil, 2009) and yielded a great 
deal of knowledge (Mogil and McCarson, 2000). By using knock-out mice, the 
physiological importance of certain genes can be explored for their involvement in pain 
either during development or in adults. For examples, knock-out studies have established 
important roles for neurotrophins and their receptors such as NGF (Crowley et al, 1994) 
and TrkA (Smeyne et al, 1994) in the development of nociceptors. Null mutations in 
cytokine genes have shown a role for interleukin (IL)-6 (Xu et al, 1997) and interferon 
(IFN)-α (Robertson et al, 1997) in the development of inflammation and neuropathic pain, 
respectively. Furthermore, the physiological and pharmacological contribution of 
receptors can be identified or verified with target deletion of receptors which are 
potentially associated with pain such as in the case of the opioid system. Results gained 
from opioid receptor knock-out mice showed that each receptor (µ, δ or κ-opioid receptor) 
was implicated in different acute pain modalities in a distinct manner and to a different 
extent, which is in line with pharmacological data (Kieffer and Gavériaux-Ruff, 2002). 
Thus, using knock-out mice together with additional pharmacological agents could 
contribute to a better understanding of pain mechanisms. In this thesis, I used ERα knock-
out (ERα-/-), ERβ knock-out (ERβ-/-) and A2AR-/- mice to elucidate their roles in the sex 
difference in pain.  
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2 AIMS OF THE THESIS 
 
The general aim of the work presented in this thesis is to study sex differences in 
experimental models of acute and chronic pain.  In particular, we want to study 
 
1. The role of estrogen receptors in sex differences in mechanical nociception, 
inflammation and in the development of neuropathic pain using knock-out mice  
2. To study the role of A2AR in nociception and inflammatory hyperalgesia using 
knock-out mice 
3. To determine sex differences in the development of acute pain-like behaviors in 
rats after spinal cord injury and to study  the impact of estrous cycle on pain 
development  
4. To determine sex differences in the development of localized and spread 
mechanical hypersensitivity in rats after infraorbital nerve injury and to study the 
impact of estrous cycle on pain development 
 12 
3 MATERIALS AND METHODS 
 
3.1 ANIMALS 
All experiments were conducted according to the Ethical Guidelines of IASP and were 
approved by the local research ethics committee (Stockholm Södra Försöksdjursetiska 
Nämd). All animals (rats and mice) were housed in standard lab conditions (22 °C; 12 h 
light/dark cycle, lights on at 6 a.m.) with access to food and water ad libitum. In paper I, 
the ERα-/- and wild-type C57BL/6 mice were from Taconic M&B (Eiby, Denmark).  The 
ERβ-/- and wild-type C57BL/6 mice were generated and supplied by the Department of 
Biosciences and Nutrition, Karolinska Institutet. In paper II, the A2AR-/- mice were 
generated and bred in the Department of Physiology and Pharmacology, Karolinska 
Institutet and the wild-type C57BL/6 mice were from Charles River (Sollentuna, 
Sweden). In papers III and IV, male and female Sprague-Dawley rats (Mollegård Ltd., 
Skensved, Denmark) were used.  
 
3.2 GENERATION OF ESTROGEN RECEPTOR KNOCK-OUT MICE 
The methods for generating ERα-/- and ERβ-/- mice have been described previously 
(Lubahn et al, 1993; Krege et al, 1998). The targeted embryonic stem (ES) cells are from 
129/J and 129P2/OlaHsd strains, respectively, and the resultant chimeras were 
backcrossed to C57/BL/6 for 10 or 8 generations before homozygous ERα-/- and ERβ-/- 
mice were generated using heterozygotes. 
 
3.3 GENERATION OF ADENOSINE A2A RECEPTOR KNOCK-OUT MICE 
The generation and breeding of the adenosine A2AR-/- mice was described previously 
(Chen et al, 1999; Halldner et al, 2004). Briefly, the mouse A2AR gene was cloned from 
mouse 129-Steel genomic library. The second coding exon was inactivated in ES cells 
with a standard replacement-type vector containing positive selection marker (PGK-Neo 
cassette). The correct integration of the mutant allele was demonstrated by Southern 
blotting, using a non-overlapping 3’ probe after digestion with BamHI (a restriction 
enzyme). One of the ES cell clones with the mutant allele was used to generate chimaeric 
mice. The chimaeric mice were bred with C57BL/6 to produce heterozygous genotype 
(A2AR+/-). Such mice were intercrossed to generate homozygous (A2AR-/-), heterozygous 
(A2AR+/-) and wild-type littermates (Chen et al, 1999). A2AR-/- mice was made on mixed 
(129-Steel x C57BL/6) genetic background, and were backcrossed for more than 10 
generations with C57BL/6 to achieve essentially pure congenic lines.  
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3.4 CARRAGEENAN-INDUCED INFLAMMATION IN MICE 
Mice were anaesthetized with chloral hydrate (300 mg/kg, i.p.). λ-carrageenan (Sigma-
Aldrich) at a concentration of 2% dissolved in 20 µl saline or 20 µl normal saline was 
injected subcutaneously (s.c.) into the plantar area of the left or right hind paw, 
respectively. The effect of carrageenan or saline on the response of the mice to 
mechanical stimuli was determined 24 h after the injection. Paw thickness was measured 
with a caliper at metatarsal level before and 24 h after the injection.  
 
3.5 PHOTOCHEMICALLY-INDUCED INJURY TO NERVES AND SPINAL 
CORD 
 
3.5.1 Sciatic nerve injury in mice 
Mice were anesthetized with chloral hydrate.  The common sciatic nerve was exposed at 
midthigh level and gently from the surrounding tissue over a distance of about 1 cm 
proximal to the trifurcation. After being injected intravenously (i.v.) with erythrosine B 
(Aldrich, 32,5mg/kg) via the tail vein, the exposed nerve was irradiated with a tunable 
argon laser (Innova model 70, Coherent Laser Products Division, Palo Alto, CA, USA) 
operating at 514 nm with an average power of 0.16 W. The interaction between the dye 
and the laser beam causes vascular occlusion and focal ischemia (Gazelius et al, 1996; 
Kupers et al, 1998; Hao, et al, 2000). The irradiation time for mice was 45 seconds. 
During the period of irradiation, a heating pad was used to maintain the body temperature 
between 37-38 °C in the mice. After irradiation the wound was closed in layers and the 
animals were returned to their home cages. 
 
3.5.2 Spinal cord injury in rats 
Under chloral hydrate anesthesia, a midline incision was made on skin overlying T12-L1 
vertebral segments. The rats were placed under the laser beam and irradiated as above at 
vertebral segment T13 (spinal cord level L4-5) for 5 or 10 min. Immediately before 
irradiation erythrosine B was injected i.v. via tail vein and the injection was repeated after 
5 min. After irradiation, the wound was closed and the rats were put back to their cages. 
During the period of irradiation, a heating pad was used to maintain the body temperature 
between 37-38 °C in rats.  
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3.5.3 Infraorbital nerve injury in rats 
Under chloral hydrate anesthesia the left infraorbital nerve was exposed via a longitudinal 
incision at the maxillary region. The different branches of the infraorbital nerve were held 
together and lifted with a glass hook while a piece of aluminium foil was placed under the 
nerve. The nerve was irradiated as above for 6 min. Immediately before irradiation 
erythrosine B was injected i.v. via tail vein and the injection was repeated after 5 min. 
After irradiation the wound was closed in layers and the rats were returned to their home 
cages for recovery. During the period of irradiation, a heating pad was used to maintain 
the body temperature between 37-38 °C in rats.  
 
3.6 BEHAVIORAL TESTS OF NOCICEPTION 
 
3.6.1 Tests of hindpaw sensitivity in mice to mechanical stimulation 
The mice were placed in plastic cages with a metal mesh floor. The plantar surface of the 
hindpaw was stimulated with a set of calibrated monofilaments (von Frey hairs, Stoelting, 
IL, USA) with increasing force until the animal withdrew the limb. The range of stimulus 
forces was from 0.008 g to 10 g. Each monolament was applied five times. The 
withdrawal threshold was taken as the force at which the animal withdrew the paw from 
at least three of ve consecutive stimuli. The experimenters were blind to the genetic 
status of the mice. 
 
3.6.2 Tests of acute mechanical hypersensitivity after spinal cord injury in rats 
Vocalization thresholds to graded mechanical touch/pressure on the back of the rats 
were tested. During testing the rats were gently restrained in a standing position and the 
von Frey hair was pushed onto the skin in dermatomes rostral to the irradiated spinal 
segment-the upper or lower back area. The frequency of stimulation was about 1/s; and 
at each intensity the stimuli were applied 5-10 times. The intensity of stimulation which 
induced consistent vocalization (>75% response rate) was considered as pain threshold. 
The cut-off value was a von-Frey hair with 100g force.  
 
3.6.3 Motor deficits after spinal cord injury  
Motor deficits after spinal cord injury were evaluated using a combined neurological 
score using four different tests (Table. 1): motor score (observation of walking in an 
open field), toe spread (spreading of toes when lifted), righting reflex and extension 
   15 
withdrawal (reflex replacement of hind leg when tested). A normal rat has a score of 0 
whereas a completely paralyzed rat has a score of  70 (Hao et al, 1996). 
Table. 1 Neurological score for evaluation of motor function of rats. 
Grade Description Points 
Motor score 
0 
1 
2 
3 
4 
5 
Toe spread 
0 
1 
2 
Righting 
0 
1 
2 
3 
Extension withdrawal 
0 
1 
2 
 
Normal walking 
Walks with only mild deficit 
Hindlimb can support weight 
Frequent movement of hindlimb, no weight bearing 
Minor movement in hindlimb, no weight bearing 
No movement of hindlimb, no weight bearing 
 
Normal full toe spread 
Partial spreading of toes 
No spreading of toes 
 
Normal righting counter to direction of the roll 
Weakened attempt to right 
Delayed to right itself 
No attempt to right 
 
Normal 
Weak and slow reflex to withdraw the hindlimb 
No withdraw reflex 
 
 
0 
5 
15 
25 
40 
45 
 
0 
2,5 
5 
 
0 
5 
10 
15 
 
0 
2,5 
5 
 
 
3.6.4 Assessment of localized and spread mechanical sensitivity after infraorbital 
nerve injury 
The von Frey filaments were applied in ascending order to the territory of the 
infraorbital nerve on the hairy skin of the vibrissal pad bilaterally. The threshold was 
taken as the force at which the rat responded by withdrawal, escape, or attack in 3 of 5 
stimuli. 
The response to mechanical stimulation of skin areas of the neck, upper and lower back, 
and flanks was also tested. During testing, the rats were gently restrained in a standing 
position, and the von Frey filament was pushed onto the skin until the filament became 
bent. The frequency of stimulation was 1/s, and at each intensity, 5 to 10 stimuli were 
applied. The intensity of stimulation, which induced consistent vocalization at >75% 
response rate, was considered a pain threshold. 
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3.7 DETERMINATION OF THE ESTROUS CYCLE IN RATS 
Vaginal smears were performed to ascertain which phase of the estrous cycle the female 
rats were in at the time of irradiation. The female rats were held vertically with one hand 
and the other hand inserted a micropipette 0.3 mm into the vaginal canal. The vagina was 
flushed three times with 10 μl 0.9% saline solution. The solution was put on a microscope 
slide and a cover glass was placed on it and examined under a light microscope. The 
smears were taken and evaluated 09:00-11:00 since the different estrous stages are more 
pronounced in the morning (Krinke, 2000). No dyes were applied since it has been shown 
that it does not significantly influence the evaluation (Marcondes et al, 2002). 
 
3.8 MORPHOLOGICAL ASSESSMENT OF SPINAL CORD INJURY IN RATS 
Morphology was performed 30 days after spinal cord injury. Rats were deeply 
anesthetized with chloral hydrate and perfused with phosphate buffer saline (PBS). Spinal 
segment L3-6 containing the irradiated area was removed and frozen immediately at  
-70°C. Transverse sections (14 µm thick) from the spinal cord were air dried, stained with 
hematoxylin and examined under a light microscope. Images were taken with a Nikon 
DXM 1200 digital camera. The epicenter of the injury was determined with an injury 
severity score. The percentage of the injured area in the epicenter was analyzed with the 
Easy Image software (version 3000). The length of the injury was also calculated as the 
distance from the beginning slice of the injury to the end slice of the injury.  
 
3.9 IMMUNOCHEMISTRY IN A2AR-/- MICE 
Wild-type and A2AR-/- mice were anesthetized with pentobarbital intraperitoneally (i.p.) 
and transcardially perfused with 4% paraformaldehyde in PBS. Brains and DRG (L4/5) 
were dissected and cryoprotected in PBS, 30% sucrose and NaN3 at 4ºC overnight. 
Tissues were sectioned on a cryostat (brain 35 µm; DRG 14 µm) and staining was 
performed either with free-floating brain sections or with DRG sections mounted on 
chrome-alum-coated slides. Sections were washed two times in PBS at room temperature 
and blocked for 1.5 h in PBTA (PBS, 0.25% Triton X-100, 3% BSA, 0.01% NaN3). 
Primary antibody (1: 200; Santa Cruz goat IgG anti A2A sc-7504 (R18)) was incubated at 
4ºC overnight. Following 3 washes in PBS, secondary antibody (1:500, Jackson 
Immunoresearch, Cy2-coupled donkey anti goat) was applied for 1.5 h at room 
temperature. After extensive washing in PBS, sections were air-dried on glass slides 
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overnight and coverslipped with DAKO fluorescent mounting medium prior to analysis 
on a Zeiss LSM510 META laser scanning microscope. 
 
3.10 REAL TIME PCR ANALYSIS IN A2AR-/- MICE 
DRGs were dissected out from wild-type and A2AR-/- mice and total RNA was isolated 
using the Totally RNA kit (Ambion) according to the manufacturer’s instructions. The 
RNA was eluted in RNAse free water. Further quality control before the microarray 
analysis was performed on an Agilent 21000 Bioanalyser (Agilent Technologies). cDNA 
synthesis was performed with the GeneAmp RNA PCR kit (Applied Biosystems) using 
random hexamers and the MuLV reverse transcriptase according to the manufacturer’s 
instructions. The adenosine A1, A2A, A2B, and A3 receptor mRNA in the DRG was 
detected by using RT-PCR (Halldner et al, 2004). Primers and probes that were used are 
described elsewhere (Chunn et al, 2001). The RT-PCR reactions were performed in 
triplicate with the TaqMan Universal PCR master mix in an ABI Prism 7000 Sequence 
Detector System (Applied Biosystems, Foster City, CA). Values are expressed as the 
difference in the number of cycles needed to reach the detection threshold (ct = cycle at 
threshold) using β-actin as a reference (∆ct = ctadenosine receptor – ctβ-actin). 
 
3.11 DRUGS AND STATISTICS 
The following drugs were used: λ-carrageenan in papers I and II, the selective A2AR 
agonist CGS21680 and the selective A2AR antagonist ZM-241,385 in paper II. All the 
drugs were from Sigma-Aldrich. λ-carrageenan and CGS21680 were dissolved in 0.9% 
saline. ZM-241,385 was dissolved in DMSO and then further diluted in cremophor EL 
and saline. 
 
Data are presented as median ± median absolute deviation (MAD) or mean ± standard 
error of the mean (SE.M). where appropriate. The data were analyzed with the Mann–
Whitney U-test, Wilcoxon Signed rank test, ANOVA with repeated measures followed by 
Fisher's PLSD test as well as paired- or unpaired t-test. All statistics were made with 
StatView on a PC computer. 
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4 RESULTS 
 
4.1  ESTROGEN RECEPTORS IN SEX DIFFERENCE IN PAIN (PAPER I) 
 
In this study, we examined the role of estrogen receptors ERα and ERβ in sex difference 
in pain using ERα-/- and ERβ-/- mice and their wild-type controls.  
 
4.1.1 Response to mechanical stimulation under normal condition 
A sex difference in withdrawal threshold to mechanical stimulation was observed in wild-
type mice for both ERα-/- and ERβ-/- mice with females exhibiting significantly lower 
response threshold than males (Fig. 1, paper I). No sex differences was seen in the ERα-/- 
and ERβ-/- mice in that the females exhibited elevated threshold, which was comparable 
to males (Fig. 1, paper I). The withdrawal threshold to mechanical stimulation in the male 
mice was similar between the knock-outs and wild-types (Fig. 1, paper I). 
 
4.1.2 Carrageenan-induced inflammation in ERα-/- and ERβ-/- mice  
Twenty-four hours after injection of carrgeenan in a hindpaw, the injected paw exhibited 
local edema in wild-type mice with no difference between the sexes (Fig. 2, paper I). 
There was also no significant difference in the extent of paw edema between the wild-
types and either ERα-/- or ERβ-/- mice (Fig. 2, paper I). 
 
All mice developed hypersensitivity to mechanical stimulation. The paw withdrawal 
threshold was significantly lower in female than in male mice 24 h after inflammation in 
both strains of wild-types (Fig 3, paper I). Again, no sex difference was observed in mice 
lacking either type of estrogen receptors, with ERα-/- and ERβ-/- females reacting similarly 
to males (Fig 3, paper I).  
 
4.1.3 Photochemically-induced sciatic nerve injury in ERα-/- and ERβ-/- mice  
Photochemically-induced sciatic nerve partial injury was generated in ERα-/- and ERβ-/- 
mice and their wild-type controls. All mice developed mechanical hypersensitivity of the 
hind paw. There were no sex differences in the extent of hypersensitivity in the two wild-
type strains (Fig. 4, paper I). There were also no differences between the knock-outs and 
their respective wild-type controls during the 28-day observation period (Fig. 4, Paper I). 
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4.2 THE ROLE OF ADENOSINE A2AR IN CARRAGEENAN-INDUCED 
MECHANICAL HYPERALGESIA AND SEX DIFFERENCE IN MICE 
(PAPER II) 
 
In this study, we examined the role of A2AR in carrageenan-induced hyperalgesia and in 
sex differences to the effects of a selective A2AR agonist and antagonist using A2AR-/- 
mice and their wild-type controls. 
 
4.2.1 Reduced hyperalgesia in A2AR-/- mice after inflammation  
A2AR-/- mice exhibited similar baseline mechanical paw withdrawal thresholds as did 
age and weight matched wild-type mice of both sexes (Fig. 1A, paper II). Both wild-
type and A2AR-/- mice developed mechanical hypersensitivity 24 h after s.c. carrageenan 
(Fig. 1A, paper II). There was no significant sex difference in either wild-types or  
A2AR-/- mice in baseline paw withdrawal thresholds and carrageenan-induced 
hyperlagesia (not shown). Although a substantial amount of hyperalgesia was also 
observed in A2AR-/- mice, the difference between the A2AR-/- mice and wild-types was 
significant in that the wild-types developed more severe hyperalgesia than the A2AR-/- 
mice. Carrageenan also produced significant paw edema 24 h after injection in both 
wild-types and A2AR-/- mice with no significant differences between the groups (Fig. 
1B, paper II). 
 
4.2.2 The effect of the A2AR antagonist ZM-241,385 on inflammatory 
hyperalgesia 
The effect of ZM-241,385 was examined in separate groups of male and female wild-
type mice. Twenty-four hours after s.c. carrageenan, as mentioned above, the wild-type 
mice developed mechanical hypersensitivity (Fig. 2, paper II). S.c. ZM-241,385 injected 
directly into the hindpaw significantly increased the paw withdrawal threshold to 
mechanical stimulation in female, but not male, mice. Vehicle produced no significant 
effect in male and female mice. Comparing to the vehicle group, ZM-241,385 showed 
significant antinociceptive effect in both males and females, but the effect was 
significantly larger in females than males (Fig. 2, paper II).  
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4.2.3 The effect of the A2AR agonist CGS 21680 on paw withdrawal threshold 
Ten µl s.c. saline injected into the paw produced a modest, but significant, decrease in 
paw withdrawal threshold for 60 min in wild-type mice (Fig. 3A, paper II). S.c. 
injection of CGS 21680 in the paw at 1 nmol/10 µl produced a more profound and 
persistent decrease in paw withdrawal threshold in the A2AR-/- mice and in the wild-
types than saline (Fig. 3A, paper II). The reduction in paw withdrawal threshold was 
significantly less in the A2AR-/- mice than in the wild-types (Fig. 3A, paper II). In the 
wild-type mice, the effect of CGS 21680 was significantly longer lasting in females 
than in males, a difference that was not seen in the A2AR-/- group (Fig. 3B, paper II). S.c. 
CGS 21680 injected into the hindpaw did not produce paw edema in any of the groups 
(data not shown). Injection of 1 nmol CGS 21680 s.c. in the neck region did not affect 
mechanical sensitivity of hindpaws in either male or female wild-type mice (Fig. 3 A, 
B, paper II).  
 
4.2.4 Low level of A2AR expression in DRG 
In order to confirm that A2AR are present in mouse DRG, which have been reported in 
rats (Kaelin-Lang et al., 1998), we examined its presence using immunohistochemistry 
employing a polyclonal goat anti-A2AR antibody (Fig. 4A, paper II). However, even 
though A2A-like immunoreactivity was readily detectable in the caudate putamen (CP), 
where A2AR expression is high, it was hardly detectable in either DRG (Fig. 4A, paper 
II) or skin (not shown). Importantly, the weak fluorescence was similar in DRG of 
A2AR-/- compare to wild-type mice. This was even more evident in skin samples from 
the mouse paw, where background immunoreactivity was comparable in wild-type and 
A2AR-/- mice (not shown). In contrast, the prominent A2A–like immunoreactivity 
detected in mouse caudate putamen was eliminated in the mice lacking the adenosine 
A2AR (Fig. 4A, right panel, paper II), underlining the specificity of the antibody. Thus, 
from the immunohistochemistry data, we conclude that the expression levels of A2AR in 
DRG is much lower than in the CP. Employing real-time PCR, on the other hand, we 
found that A2AR mRNA is detected in mouse DRG to an extent similar to A2BR mRNA, 
but far less than A1R mRNA. A3R mRNA was almost undetectable (Fig. 4B, paper II). 
Comparable real-time PCR studies using cDNA from mouse CP resulted in a 2-Δct value 
for A2AR expression that was 0.096 (i.e. about two orders of magnitude higher than in 
DRG) supporting our findings from the immunohistochemistry on lower levels of A2AR 
expression in the DRG.  
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4.3 SEX DIFFERENCES IN THE DEVELOPMENT OF ALLODYNIA IN RATS 
AFTER SPINAL CORD INJURY (PAPER III) 
 
In this study, we assessed sex differences in the development of acute allodynia in rats 
after photochemically-induced spinal cord injury and the impact of the stage of the estrous 
cycle at the time of injury. 
4.3.1  Sex differences in acute allodynia 
The vocalization threshold to mechanical stimulation of the flank and upper back area in 
normal rats was 80-100 g with no significant difference between males and females. 
Within 1 day after spinal cord irradiation for 5 or 10 min, female rats showed markedly 
decreased response threshold to mechanical stimulation in these regions (Fig. 1A, B, 
paper III). In contrast, there was no significant decrease in mechanical response threshold 
in male rats after 5 min irradiation (Fig. 1A, paper III). After 10 min irradiation, male rats 
also showed significant decrease in vocalization threshold (Fig. 1B, paper III). There was 
a significant sex difference between males and females after 10 min irradiation with 
females having lower threshold and slower recovery (Fig. 1B, paper III).  
 
4.3.2 No impact of estrous cycle  
Estrous stage was controlled in female rats at the time of the spinal cord injury and no 
significant differences were observed in baseline vocalization threshold and mechanical 
hypersensitivity after spinal cord injury among three groups of female rats irradiated at 
different stages of the estrous cycle (Fig. 2, paper III). 
 
 
4.3.3  Sex difference in acute allodynia is not due to difference in the extent of 
injury 
Motor deficits were evaluated and morphological analysis was conducted after spinal cord 
injury to determine if sex difference after spinal cord injury was due to different 
magnitude of injury in male and female rats. Both male and female rats developed 
moderate neurological motor deficits after 5 or 10 min spinal cord irradiation. There was 
no significant difference in combined neurological scores between males and females (Fig. 
3A, Paper III). Morphological comparison was made in rats after 10 min spinal cord 
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irradiation which produced moderate injury to dorsal spinal cord (Fig. 3B, Paper III). No 
significant differences were observed between males and females in the magnitude of the 
injured area in the epicenter or to the length of injury (Fig.4, Paper III).  
 
4.4  SEX DIFFERENCES IN THE DEVELOPMENT OF ALLODYNIA IN 
RATS AFTER INFRAORBITAL NERVE INJURY (PAPER IV) 
 
In this study, we assessed sex differences in the development of localized and spread 
mechanical allodynia in rats after infraorbital nerve injury and the impact of estrous cycle 
at the time of and after injury. 
4.4.1 Baseline response threshold to mechanical stimulation 
A significant difference in baseline threshold to mechanical stimulation was found 
between male and female rats both in the facial and at the upper flank region (Fig. 1A, 
paper IV) with normal females having significantly lower threshold on the face and upper 
flank region compared to males. Females tested at different stages of estrous cycle did not 
show significant difference in baseline response threshold on either the face or upper 
flank (Fig. 1A, B, paper IV). 
 
4.4.2 Sex difference in the development of localized and spread allodynia 
After infraorbital nerve injury, both males and females developed mechanical 
hypersensitivity on the ipsilateral face and upper flank and back region. The 
hypersensitivity was significantly more severe and prolonged in females (Fig. 2A, B, 
paper IV). ANOVA with repeated measurement indicated a significant overall difference 
between the two sexes during the observation period and there was an interaction between 
sex and time (Fig. 2A, B, paper IV). 
 
4.4.3 Lack of impact by estrous stage on mechanical hypersensitivity after 
infraorbital nerve injury  
When the females were divided into the three different estrous stages at the time of 
irradiation, there was no significant difference in the pattern of hypersensitivity 
development on the face and upper flank among the groups (Fig. 3A, B, paper IV). 
During weeks 1-3 and 12-14 after infraorbital nerve injury, hypersensitivity on the face 
and flank were tested daily for 15 days to cover 3 continuous estrous cycles. Comparison 
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was made among each estrous stage both in face and upper flank region. After injury, 
only 10% of the females exhibited regular cycles (data not shown). However, it was still 
possible to identify various estrous stages through vaginal smear. No significant 
difference of mechanical hypersensitivity was found in the face or upper flank region 
across the estrous stages (Fig. 4A, B, paper IV). The hypersensitivity on the face was 
significantly less during weeks 12-14 compared to weeks 1-3 after the injury. In contrast, 
the hypersensitivity on the flanks during weeks 12-14 was similar to weeks 1-3, 
suggesting spread hypersensitivity was more persistent than localized hypersensitivity.  
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5 DISCUSSION 
 
5.1 SEX DIFFERENCE IN PAIN SENSITIVITY IN RODENTS 
 
Sex difference in nociceptive response in rodents, with females generally being more 
sensitive, has been shown in previous studies using several nociceptive assays, including 
the von Frey test as used in our studies (Mogil et al, 2000; Chesler et al, 2002; 
Chillingworth et al, 2006). In paper I, such difference again was demonstrated in both 
strains of wild-type mice for estrogen receptor knock-out mice in baseline paw 
withdrawal threshold to mechanical stimulation. In paper II, however, we did not observe 
a significant sex difference in baseline mechanical pain threshold in wild-type mice and 
A2AR-/- mice. Similarly we also noted that in Sprague-Dawley rats, sex difference was not 
readily observed for basal mechanical pain threshold. In study IV, there was a significant 
sex differences for response threshold for mechanical stimulation on the face and upper 
back region whereas in study III, such difference was not significant for the trunk and 
lower back region. Influence of site of testing on determination of sex difference has also 
been previously noted in our and other laboratories (Pajot et al, 2003; Dominguze et al, 
2009).  It is thus suggested that although sex difference in basal mechanical pain threshold 
can be demonstrated in rodent, the magnitude of such difference is moderate and 
subjected to influence by many factors. One of such factor is genetic as it has been shown 
that sex difference in pain responses in rodents has been shown to be strain dependent 
(Kest et al, 2000; Deleo and Rutkowski, 2000; LaCroix-Fralish, 2005a) which may 
explain the lack of sex difference observed in wild-types for A2AR-/- mice as it has 
different genetic background than the wild-types for ERα-/- and ERβ-/- mice.  
 
In study I, we also observed that after carrgeenan-induced inflammation, the paw 
withdrawal threshold in female mice was significantly lower than that in males while in 
study II, the sex difference did not reach significance after inflammation. This may also 
be explained by genetic differences between the strains. Another point which needs to be 
considered is that since there is a sex difference in baseline paw withdrawal threshold 
with females having low threshold, the relative change after inflammation may not show 
sex difference. However, we consider it is more relevant to consider the actual threshold 
after inflammation to determine sex difference as in a clinical setting, pain sensitivity 
before diseases is not usually considered as a factor.  
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5.2     THE INVOVEMENT OF ERα AND ERβ IN SEX DIFFERENCE IN PAIN 
 
As mentioned in paper I, sex difference was demonstrated in both strains of wild-type 
mice in baseline to mechanical stimulation. Male ERα-/- and ERβ-/- had similar baseline 
mechanical response threshold as their wild-type controls. However, female ERα-/- and 
ERβ-/- exhibited signicantly elevated response threshold, comparable to males, under 
normal conditions. Thus, the sex difference observed in baseline between wild-type males 
and females was eliminated in the knock-outs, suggesting a role of ERα or ERβ in 
determining sex difference in baseline nociception. 
 
The same direction of sex difference in carrageenan-induced mechanical hyperlagesia was 
also observed in wild-type mice. Both male and female wild-type controls developed 
similar extent of paw edema, suggesting that the increased mechanical hypersensitivity in 
females does not seem to be caused by an increased inammatory response. Again, such 
sex difference was eliminated in ERα-/- and ERβ-/-. Our results agree to some extent with 
those of Spooner et al. (2007) in which female ERβ-/- mice showed reduced response in 
the formalin test compared to wild-type controls. These authors did not nd that ERβ 
ablation inuenced hot plate latency in females, although there was a sex difference with 
females being more sensitive than males. This difference from our results may be due to 
the difference in stimulation and tests used. The lack of phenotypic changes in the male 
knock-outs suggests that the difference seen in the females does not reflect a generalized 
action of estrogen or differences in background genes, but rather a sex-specic role of 
estrogen in mechanical nociception and important in determining sex differences. 
 
No sex difference was seen in mechanical hypersensitivity after partial sciatic nerve 
injury in wild-type or knock-out mice. This is similar to our previous results in rats 
(Dominguez et al, 2009). Sex difference in the development of neuropathic pain-like 
behaviors after nerve injury in rodents has not been consistently reported and may be 
related to the strains of animal used and experimental models (Deleo and Rutkowski, 
2000; LaCroix-Fralish et al, 2005b). The lack of difference between the knock-out male 
and females suggests again that the role of estrogen receptors in mechanical nociception is 
sex-specific and important in determining sex differences. It should be noted that in the 
clinical setting sex differences are observed in the prevalence of many neuropathic pain 
conditions (Greenspan et al, 2007). 
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It is not clear which estrogen and its receptors mediate sex difference in mechanical 
nociception in mice. We also do not know whether the two estrogen receptors play the 
same or different roles in this process, despite similar phenotypes. Exogenously applied 
estrogen has been shown to increase pain response in rodents, although the effect is not 
sex-specic (Aloisi and Ceccarelli, 2000; Craft et al, 2004). The increase in mechanical 
response threshold in female knock-outs may be due to the removal of an ongoing 
activational excitatory effect by estrogen in adult female mice. Estrogen receptors have 
different functions during neurogenesis. ERα activation induces increased length and 
number of neurites, whereas ERβ activation modulates only neurite length (Papka et al, 
2003). ERβ is also essential for morphogenesis and maintenance of the spinal dorsal horn 
interneurons (Fan et al, 2007). Thus, the phenotype observed in the female knock-outs 
may also be due to the developmental changes in female mice brought about by the 
organizational effect of estrogen during development. 
 
5.3 A2AR ACTIVATION IN INFLAMMATORY HYPERALGESIA AND SEX 
DIFFERENCES IN PAIN 
 
We observed that A2AR-/- mice and their wild-type controls displayed similar baseline 
nociceptive response to mechanical stimulation, which is in contrast to the A1R-/- mice 
that showed reduced mechanical threshold under normal conditions in a previous study 
(Johansson et al, 2001; Wu et al, 2005). This suggests that unlike the A1R, the A2AR may 
not be involved in determining mechanical pain threshold under normal conditions.  
 
After inflammation, both A2AR-/- and wild-type mice developed mechanical 
hypersensitivity after 24 h that was associated with paw edema. The magnitude of 
hypersensitivity was significantly reduced in A2AR-/- mice compared to wild-types. The 
extent of paw edema was similar between A2AR-/- and the wild-type mice, indicating that 
the reduction in mechanical hypersensitivity in the A2AR-/- mice is not directly related to 
the extent of peripheral inflammation. In a previous study, we observed that A3R-/- mice 
exhibited a reduction of inflammatory hyperalgesia to heat stimulation, which was related 
to the extent of inflammation in the paw (Wu et al, 2002).  
 
Although no sex difference was found in inflammatory hyperalgesia and paw edema in 
wild-type or A2AR-/- mice, a pharmacological sex difference were found in response to an 
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A2AR agonist and antagonist. The selective A2AR antagonist ZM-241,385 reduced 
inflammatory hypersensitivity upon direct local injection, which was more effective in 
females. In line with this observation, we found local injection of the A2AR agonist CGS 
21680 produced a hyperalgesic effect, which was again more profound in the wild-type 
females than in males. This indicates that the A2AR is involved in the inflammatory 
hyperalgesic response to carrageenan and a sex difference in response to A2AR activation 
in the periphery. However, sex differences in response to A2AR activation did not appear 
to be sufficiently large to impact sex differences in inflammatory hypersensitivity in the 
present study.  
 
We do not know which type of cell(s) that is responsible for the effect of A2AR activation 
on pain sensitivity. It is well known that A2ARs are present on many types of cells in the 
immune system (Fredholm et al, 2001).  The present data confirm that cells in the DRG, 
perhaps neurons, express A2AR mRNA, and hence probably the receptor. The expression 
level is, however, not high. Despite this uncertainty the results suggest that peripheral 
actions of A2AR antagonists may be relevant in controlling some types of pain.  Caffeine 
(and its metabolites theophylline and paraxanthine) are A2AR antagonists, and caffeine is 
a known additive in several pain medications (Sawynok, 1998). 
 
5.4 SEX DIFFERENCE IN THE DEVELOPMENT OF NEUROPATHIC PAIN-
LIKE BEHAVIORS IN RATS  
 
We conducted two neuropathic-pain models in rats with ischemic spinal cord injury and 
infraorbital injury in paper III and paper IV respectively. In paper III, we showed a 
significant sex difference in the development of acute allodynia-like behavior with female 
rats being more sensitive than male rats after ischemic spinal cord injury. This sex 
difference cannot be explained by the small and insignificant difference in mechanical 
sensitivity between the sexes before injury, nor by differences in the extent of injury. Our 
results agree with that of Gorman et al. (2001) who showed, using a rat model of spinal 
cord injury-induced spontaneous pain (the excessive grooming behavior), that although 
the characteristics of such behavior were similar between males and females, the female 
rats developed grooming with less spinal damage than males. Similarly, in paper IV, a 
significant sex difference was also found in the development of localized and wide spread 
mechanical hypersensitivity in rats after infraorbital nerve injury. These findings agree 
with our previous results using the same model (Dominguez et al, 2009).  
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One interesting observation from the work presented in Study III and IV is that the sex 
differences appear to be more prominent in wide-spread allodynia after spinal cord injury 
and infraorbital nerve injury (See also Dominguez 2009). As spinal cord injury-induced 
acute allodynia has been shown to be caused primarily by a dysfunction of the 
GABAergic inhibitory system in spinal cord (Hao et al, 1991 and 1992; Zhang et al, 
1994), these results suggest that sex differences in the spinal GABAergic system may be 
an important underlying mechanism in sex differences in pain after spinal cord injury. 
Previous studies have shown that there is a close association between sex hormones and 
GABA in many aspects of neural function (Berkley, 1997). Estrogen increases GABA 
release, upregulates GABA receptors and increases the activity of glutamate acid 
decarboxylase (Kelly et al, 1992; Weiland, 1992; Saleh and Connell, 2003). 
 
It is unclear what the mechanisms for sex difference after infraorbital injury. In the 
trigeminal region, there is an increased expression of glutamate NR2B subunit in masseter 
ganglion neurons in female rats compared with male rats after glutamate injection (Dong 
et al, 2007). Furthermore, greater afferent discharge has been found in females than males 
after glutamate injection into this area, which may be involve in the observed sex 
difference in the trigeminal region (Carins et al, 2002; Dong et al, 2007). Generally, the 
plasma level of sex hormones is not necessarily correlated with the level within the CNS 
levels (e.g. PAG, spinal cord and DRG) since sex steroids can be synthesized locally in 
the spinal cord (Murphy and Hoffman, 2001; Evrard and Balthazart, 2004; Evrard, 2006). 
It might be also the case for trigeminal complex due to the significant expression of 
steroidogenic enzyme (Horvath and Wikler, 1999). This might at least partly explain the 
absence of significant correlations between estrous phase and development of mechanical 
hypersensitivity. Clearly, further studies are needed to clarify the mechanisms in sex 
differences after spinal cord injury and infraorbital nerve injury. 
 
5.5 ESTROUS STAGE AND THE DEVELOPMENT OF NEUROPATHIC 
PAIN-LIKE BEHAVIORS 
 
The baseline sensitivity to mechanical stimuli of female rats was also tested at each 
estrous stage before nerve injury in papers III and IV. In paper III, the baseline 
nociception of the trunk area did not change across different estrous stages. Similarly, in 
paper IV the basal nociception in facial area and upper flank also did not exhibit 
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significant change related to different estrous stage. This suggested that different estrous 
stage has little effect on basal nociception under normal conditions in our testing regime.  
 
Due to the fact that some painful conditions are related to menstrual cycle in humans 
(Greenspan et al, 2007), it is of interest to study whether there are estrous stage related 
pain in our experimental pain models. Studies with ovariectomized female rodents 
suggested a facilitatory role for female sex hormones in the development of pain-related 
behaviors following sciatic nerve and spinal cord injury (Colye et al, 1996; Gorman et al, 
2001). From this perspective, we controlled the estrous stage at the time of injury and/or 
two time points after nerve injury to see if the development of hypersensitivity was 
affected by different estrous stages. In paper III, we observed that estrous stages at the 
time of spinal cord injury did not affect development of acute allodynia in female rats. In 
lines with this observation, different estrous stage at the time of infraorbital nerve 
irradiation was not found to influence the severity and duration of the hypersensitivity in 
either face or upper flank region in paper IV. This indicates that the magnitude of 
hypersensitivity is not dependent on specific estrous phase at the onset of the injury.  
 
The changes of hypersensitivity across the estrous cycle were also examined in female 
rats in paper IV. The variation of hypersensitivity across the estrous cycle during a 15-day 
evaluation at 1-3 weeks and 12-14 weeks post nerve injury did not reveal an impact of 
estrous stage on mechanical sensitivity. However, the animals started to recover from the 
injury at 12-14 weeks at the face region, but not in the flank areas involved in spread 
sensitivity. Modulation of nociceptive behaviors in different stages of the estrous cycle 
has been reported previously in some, but not all, studies (Marks and Hobbs, 1972; Frey 
et al, 1993; Martinez-Gomez et al, 1994; Vincler et al, 2001). Vincler et al. (2001) 
showed that modulation of nociceptive behaviors during the estrous cycle is dependent on 
the type and duration of stimulus used. Thus it could be the same case in paper III and IV. 
Thus, the impact of estrous cycle on normal nociception and hypersensitivity to 
mechanical stimulus seems to be minimal in our testing paradigm. 
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6 CONCLUSIONS 
 
 
1. ERα and ERβ are involved in determining sex difference in mechanical sensitivity 
under normal condition and after inflammation, but they do not appear to have a 
role in the development of mechanical hypersensitivity after sciatic nerve injury. 
2. Activation of peripheral adenosine A2AR is involved in mechanical hyperalgesia 
after inflammation and the effect of A2AR activation is more profound in females 
than in males. 
3. Females develop more profound acute mechanical allodynia after spinal cord 
injury which is independent of the extent of tissue injury or specific estrous phase 
at the time of injury. 
4. There are sex differences in the development of localized and spread mechanical 
hypersensitivity after infraorbital injury in rats. However, there appears to be no 
change in hypersensitivity across estrous cycle in females.  
   31 
7 ACKNOWLEDGEMENTS 
 
These studies were performed at the Department of Clinical Neuroscience and 
Department of Physiology and Pharmacology. I would like to express my sincere 
gratitude to all the people who have helped me in every aspect of my Ph.D education and 
life in Sweden. In particular, I would like to thank: 
 
My supervisor, Docent Xiao-Jun Xu, for accepting me to work with you. For generously 
sharing your profound knowledge in pain research. For your enthusiastic discussion and 
advices about science and carrier. Your positive, constructive ideas and careful analysis 
have led and nourished me to develop as a better scientist. Working with you has been a 
great honor to me. A four-year education is not long enough to learn from you not only 
about science but also about philosophy in life. 
 
My co-supervisor, Prof. Zsuzsanna Wiesenfeld-Hallin, for giving me this great 
opportunity to work in your lab. For your outstanding scientific ideas and professional 
excellence in pain research. For your great support, encouragement, and perfect pace-
control of the thesis. For the family-like working environment you created. All the warm 
hugs and patting on the shoulders are unforgettable! Working with you is a great honor 
and a pleasant journey. Special thanks to Associate Prof. Rolf Hallin for your hospitality 
and kindness during every visit to your home.     
 
Dr. Jing-Xia Hao, my co-author and tutor in experimental techniques, for passing and 
sharing your excellent skills. For your advices and help in all practical matters. For taking 
care of me and my family. For introducing me to the delight of Peking Opera and making 
me ´´addicted´´ to this fantastic traditional Chinese art. 
 
Prof. Bertil Fredholm, at the Department of Physiology and Pharmacology, thank you for 
all the discussions, guidelines, profound knowledge in the field of research on adenosine. 
I also appreciate the help of Frank Brand in generating the confocal images of DRGs and 
Eva Lindgren in performing the real-time PCR. Docent. Gunnar Schulte at the 
Department of Physiology and Pharmacology, for your valuable contribution, comments 
and corrections for the second paper.  
 
 32 
Prof. Kaj Fried at Department of Department of Dentistry (DENTMED), thanks for being 
my mentor, all the references you selected for me to read, and for your always being there 
whenever I need a help. 
 
Prof. Patrik Ernfors at Department of Medical Biochemistry and Biophysics, for the 
exciting collaboration projects and opening a door for me to deepen my knowledge in 
neuroscience. The opportunity you give me to do a post doc at your lab is a strong 
inspiration for me to develop my scientific career.  
 
Prof. Stefan Eriksson, head of the Department of Physiology and Pharmacology, for bring 
our group to the Department and for creating a pleasant working environment.  
 
Special thanks Dr Hong Wei from Institute of Biomedicine and Physiology, University of 
Helsinki, for introducing me to Prof. Zsuzsanna Wiesenfeld-Hallin’s Lab when I was a 
master student in Shanghai. Thank you very much for your help and honest friendship. 
Without you, I would not be able to be guided by world-famous scientists.  
 
Prof. Wu Chunfu and Associate Prof. Liu Zheng, Department of Pharmacology, 
Shenyang Pharmaceutical University, China, for introducing me to medical research and 
your help in the early days of my research career.     
 
Prof. Ernst Brodin, Assistant Prof. Camilla Svensson and Prof. Linda Sorkin from 
University of California, USA, for your discussion in FyFa around journal clubs.  
 
Past and current members of the group: Daniel Andersson for the pleasant collaboration 
in paper III. Dr Wei-Ping Wu, for being such a nice friend like a big sister, the time with 
you is always full of laughs, and you always make me feel very good about myself. Anna-
Karin Persson for your kindness during my early days in Sweden and wonderful time 
spent together during our conferences. Tianle Gao, for your friendship both at and after 
work, and your generous help with the experiment when I was on vacation and the tough 
times when I was suffering low back pain.  
 
Dr. Cecilia Dominguez, what can I say? You are like a sister and a friend, and always 
give efficient help, comfort, and encouragement whenever I am upset with both work and 
personal life. Your patience and calm always make me comfortable and refresh. Thanks 
   33 
for inviting me to your wedding and all the parties at your home which helped me go 
through the tough and lonely days in Sweden. Special thanks to your husband Marcello, 
for the elegant and fancy Swedish cousin, warm welcome and funny jokes every time at 
your home. 
 
Marina Franck and Isabelle Bachy at Department of Medical Biochemistry and 
Biophysics, thanks for transportation of the testing facilities and the nice discussion with 
the two collaborating papers. 
 
All the personnel in the animal department at Clinical Neuroscience and FyFa, for taking 
such good care of the animals. All the administration personnel at department of 
Physiology and Pharmacology, in particular, Camilla Fors Holmberg, Freddie Hellström, 
Peter Wolf, Renée Andersson and Micke Elm, thanks that you are always ready to help 
with any problems. 
 
To all my Chinese friends, whom I met in Sweden, for helping me, sharing life stories and 
having a lot fun: Zhu Shun-Wei, Yu Jiang, Yan Hong-Mei, Yu Hong, Xue Yuan and Hu 
Ying-Wei; Wang Xin, Zheng Xiao-Feng, Wan Min, Fang Fang, Shu Nanjiang, for so 
much fun when talking to you; Huang Li-Yue, Wang Ying-Qing, Qi Hongshi, Zhang 
Xiaoqun, Zhang Xingmei, Song Zhiyang, Wang Xiaoda for sharing the funny jokes 
during lunch and in KI bus. 
 
To all my Peking Opera team members: Wu Jiang-Yan, it is a great luck to learn opera 
with you. Xu Bo, Wang Xiao, Qian Yi, Liu Ying, Liu Yun, being together with you 
during every opera practice is such a happy thing. 
 
Special thanks to my family: grandma and grandpa, who brought me up as your favorite 
grandkid, for your unconditional love during my childhood.  My parents and sister, thanks 
for all the love, kindness, wisdom, sacrifice and encouragement from you. You are always 
my home whenever I need a comfort. My brother-in-law, thanks for your support. My 
niece, Tongtong, thanks for your pleasant words which makes me happy.  
 
Jinling, my husband and best friend, thank you for your solid support, endless patience 
and love.  
 34 
8 REFERENCES 
 
Aloisi AM, Ceccarelli I. Role of gonadal hormones in formalin-induced pain responses of 
male rats:  odulation by estradiol and naloxone administration.  Neuroscience 
2000;95:559–566. 
Aloisi AM, Craft RM, Marchand S. The effects of gonadal hormones on pain. In: Flor H, 
Kalso E, and Dostrovsky JO (Eds.) Proceedings of the 11th World Congress on 
Pain. IASP Press, Seattle, 2006, pp. 301-308. 
Amandusson A, Hallbeck M, Hallbeck AL, Hermanson O, Blomqvist A. Estrogen-
induced alterations of spinal cord enkephalin gene expression. Pain 1999;83:243–
248. 
Amandusson A, Hermanson O, Blomqvist A. Colocalization of oestrogen receptor 
immunoreactivity and preproenkephalin mRNA expression to neurons in the 
superficial laminae of the spinal and medullary dorsal horn of rats. Eur J Neurosci 
1996;8:2440-2445. 
Ascenzi P, Bocedi A, Marino M. Structure-function relationship of estrogen receptor 
alpha and beta: impact on human health. Mol Aspects Med 2006;27:299-402.  
Barrett AC, Smith ES, Picker MJ. Sex-related differences in mechanical nociception 
and antinociception produced by mu- and kappa-opioid receptor agonists in rats. 
Eur J Pharmacol 2002;452:163-173.  
Baron R, Binder A, Wasner G. Neuropathic pain: diagnosis, pathophysiological 
mechanisms, and treatment. Lancet Neurol 2010;9:807-819. 
Basbaum A Bushnell C, Devor M. Pain: Basic Mechanisms. In: Castro-Lopes J, Raja S 
and Schmelz M (Eds.) Un updated review, Refresher course syllabus. IASP press, 
Seattle, 2008, pp. 3-10. 
Basbaum AI, Bautista DM, Scherrer G, Julius D. Cellular and molecular mechanisms of 
pain. Cell 2009;16:267-284. 
Basbaum AI, Jessell T. The perception of pain. In: Kandel ER, Schwartz J, and Jessell T  
(Eds.) Principles of Neuroscience. Appleton and Lange, New York, 2000, pp. 472–
491. 
Bennett GJ, Xie YK. A peripheral mononeuropathy in rat that produces disorders of 
pain sensation like those seen in man. Pain 1988;33:87-107.  
Berglund LA, Simpkins JW. Alterations in brain opiate receptor mechanisms on 
proestrous afternoon. Neuroendocrinology 1988;48:394-400. 
Berkley KJ. Sex differences in pain. Behav Brain Sci 1997;20:371-380. 
Berkley KJ, Zalcman SS, Simon VR. Sex and gender differences in pain and 
inflammation: a rapidly maturing field. Am J Physiol Regul Integr Comp Physiol 
2006;291:R241-244.  
Boddeke EW. Involvement of chemokines in pain. Eur J Pharmacol 2001;429:115-119. 
   35 
Borzan J, Fuchs PN. Organizational and activational effects of testosterone on 
carrageenan-induced inflammatory pain and morphine analgesia. Neuroscience 
2006;143:885-893.  
Brandes JL. The inuence of estrogen on migraine: a systematic review. JAMA 
2006;295:1824–1830. 
Brown, AG. Organization in the Spinal Cord: The Anatomy and Physiology of Identified 
Neurones. In: Brown AG, Springer-Verlag, Berlin, 1981.   
Butcher RL, Collins WE, Fugo NW. Plasma concentration of LH, FSH, prolactin, 
progesterone and estradiol-17beta throughout the 4-day estrous cycle of the rat. 
Endocrinology 1974; 94:1704-1708. 
Butler TR, Smith KJ, Berry JN, Sharrett-Field LJ, Prendergast MA. Sex differences in 
caffeine neurotoxicity following chronic ethanol exposure and withdrawal. Alcohol 
Alcohol 2009;44:567–574.  
Butler TR, Smith KJ, Self RL, Braden BB, Prendergast MA. Sex differences in the 
neurotoxic effects of adenosine A1 receptor antagonism during ethanol withdrawal: 
reversal with an A1 receptor agonist or an NMDA receptor antagonist. Alcohol Clin 
Exp Res 2008;32:1260–1270. 
Cairns BE, Gazerani P. Sex-related differences in pain. Maturitas 2009;20:292-296.  
Cairns BE, Gambarota G, Svensson P, Arendt-Nielsen L, Berde CB. Glutamate-induced 
sensitization of rat masseter muscle fibers. Neuroscience 2002;109:389-399. 
Cervero F, Iggo A, Ogawa H. Nociceptor-driven dorsal horn neurones in the lumbar 
spinal cord of the cat. Pain 1976;2:5-24. 
Chanda ML and Mogil JS. Sex differences in the effects of amiloride on formalin test 
nociception in mice. Am J Physiol Regul Integr Comp Physiol 2006;291:R335–
R342. 
Chen JF, Huang Z, Ma J, Zhu J, Moratalla R, Standaert D, Moskowitz MA, Fink JS, 
Schwarzschild MA. A(2A) adenosine receptor deficiency attenuates brain injury 
induced by transient focal ischemia in mice. J Neurosci 1999;19:9192-9200. 
Chesler EJ, Wilson SG, Lariviere WR, Rodriguez-Zas SL, Mogil JS. Identication and 
ranking of genetic and laboratory environment factors inuencing a behavioral trait, 
thermal nociception, via computational analysis of a largedata archive. Neurosci 
Biobehav Rev 2002;26:907–923  
Chillingworth NL, Morham SG, Donaldson LF. Sex differences in inammation and 
inammatory pain in cyclooxygenase-decient mice. Am J Physiol Regul Integr 
Comp Physiol 2006;291:R327–334. 
Christensen MD, Everhart AW, Pickelman JT, Hulsebosch CE. Mechanical and thermal 
allodynia in chronic central pain following spinal cord injury. Pain 1996;68:97-
107. 
Chunn JL, Young HW, Banerjee SK, Colasurdo GN, Blackburn MR. Adenosine-
dependent airway inammation and hyperresponsiveness in partially adenosine 
deaminase-decient mice. J Immunol 2001;167:4676–4685. 
 36 
Cicero TJ, Nock B, O'Connor L, Meyer ER. Role of steroids in sex differences in 
morphine-induced analgesia: activational and organizational effects. J Pharmacol 
Exp Ther 2002;300:695-701. 
Clemente JT, Parada CA, Veiga MC, Gear RW and Tambeli CH, Sexual dimorphism in 
the antinociception mediated by kappa opioid receptors in the rat 
temporomandibular joint. Neurosci Lett 2004;372:250–255. 
Cook CD, Barrett AC, Roach EL, Bowman JR, Picker MJ. Sex-related differences in 
the antinociceptive effects of opioids: importance of rat genotype, nociceptive 
stimulus intensity, and efficacy at the mu opioid receptor. Psychopharmacology  
2000;150:430-442. 
Cooke B, Hegstrom CD, Villeneuve LS, Breedlove SM. Sexual differentiation of the 
vertebrate brain: principles and mechanisms. Front Neuroendocrinol 1998;19:323-
362.  
Craft RM. Sex differences in opioid analgesia: "from mouse to man". Clin J Pain 
2003;19(3):175-186.  
Craft RM, Mogil JS, Aloisi AM. Sex differences in pain and analgesia: the role of 
gonadal hormones. Eur J Pain 2004;8:397–411. 
Craft  RM. Modulation of pain by estrogens. Pain 2007;132:S3-12.  
Crowley C, Spencer CD, Nishimurai MC. Mice lacking nerve growth factor display 
perinatal loss of sensory and sympathetic neurons yet develop basal forebrain 
cholinergic neurons. Cell 1994;76:1001–1011. 
Coyle DE, Sehlhorst CS, Behbehani MM. Intact female rats are more susceptible to the 
development of tactile allodynia than ovariectomized female rats following partial 
sciatic nerve ligation (PSNL). Neurosci Lett 1996;12:37-40. 
DeLeo JA, Rutkowski MD. Gender differences in rat neuropathic pain sensitivity is 
dependent on strains. Neurosci Lett 2000;282:197–199.  
Derbyshire SWG, Nichols TE, Firestone L, Townsend DW, and Jones AKP. Gender 
differences in patterns of cerebral activation during equal experience of painful laser 
stimulation. J Pain 2002;3:401–411,  
D'Mello R, Dickenson AH. Spinal cord mechanisms of pain. Br J Anaesth 
2008;101(1):8-16.  
Deuchars SA, Brooke RE, Deuchars J. Adenosine A1 receptors reduce release from 
excitatory but not inhibitory synaptic inputs onto lateral horn neurons. J Neurosci 
2001;21:6308-6320.  
Deroo BJ, Korach KS. Estrogen receptors and human disease. J Clin Invest 
2006;116:561-570. 
Dina OA, Gear RW, Messing RO, Levine JD. Severity of alcohol-induced painful 
peripheral neuropathy in female rats: role of estrogen and protein kinase (A and 
Ce). Neuroscience 2007;145:350–356. 
   37 
Dolphin AC, Forda SR, Scott RH. Calcium-dependent currents in cultured rat dorsal-root 
ganglion neurons are inhibited by an adenosine analog. Journal of Physiology-
London 1986;373:47-61. 
Dominguez CA, Kouya PF, Wu WP, Hao JX, Xu XJ, Wiesenfeld-Hallin Z. Sex 
differences in the development of localized and spread mechanical 
hypersensitivity in rats after injury to the infraorbital or sciatic nerves to create a 
model for neuropathic pain. Gend Med 2009;6:225-234. 
Dong XD, Mann MK, Kumar U, Svensson P, Arendt-Nielsen L, Hu JW, Sessle BJ, 
Cairns BE. Sex-related differences in NMDA-evoked rat masseter muscle afferent 
discharge result from estrogen-mediated modulation of peripheral NMDA receptor 
activity. Neuroscience 2007;146:822-832. 
Dunwiddie TV, Masino SA. The role and regulation of adenosine in the central nervous 
system. Annual Review of Neuroscience 2001;24:31-55. 
Eldrup E, Lindholm J, Winkel P. Plasma sex hormones and ischemic heart disease. Clin 
Biochem 1987;20:105-112. 
Ektor-Andersen J, Janzon L, Sjölund B. Chronic pain and the socio-demographic 
environment: results from the pain clinic at Malmö General Hospital in Sweden. 
Clin J Pain 1993;9:183-188. 
Evrard HC. Estrogen synthesis in the spinal dorsal horn: a new central mechanism for 
the hormonal regulation of pain. Am J Physiol Regul Integr Comp Physiol 
2006;291:291-299. 
Evrard HC, Balthazart J. Rapid regulation of pain by estrogens synthesized in spinal 
dorsal horn neurons. J Neurosci 2004;24:7225-7229. 
Fan X, Xu H, Warner M, Gustafsson JA. ERbeta in CNS: new roles in development and 
function. Prog Brain Res 2010;181:233-250. 
Fan XT, Kim HJ, Warner M, Gustafsson JÅ. Estrogen receptor β is essential for 
sprouting of nociceptive primary afferents and for morphogenesis and 
maintenance of the dorsal horn interneurons. Proc Natl Acad Sci USA 
2007;104:13696-13701. 
Fillingim RB, Edwards RR, Powell T. The relationship of sex and clinical pain to 
experimental pain responses. Pain 1999;83:419-425. 
Fillingim RB, Ness TJ. Sex-related hormonal influences on pain and analgesic 
responses. Neurosci Biobehav Rev 2000;24:485-501.  
Fitzcharles MA, Lussier D, Shir Y. Management of chronic arthritis pain in the elderly. 
Drugs Aging 2010;27:471-490.  
Fredholm BB, IJzerman AP, Jacobson KA, Klotz KN, Linden J. International Union of 
Pharmacology. XXV. Nomenclature and classification of adenosine receptors. 
Pharmacol Rev 2001;53:527-552. 
Fredholm BB. Adenosine and neuroprotection. Int Rev Neurobiol 1997;40:259-280.  
Frey CA, Cuevas Ca, Kanarek RB. Diet and estrous cycle influence pain sensitivity in 
rats. Pharmacol Biochem Behav 1993;45:255-260. 
 38 
Gazelius B, Cui JG, Svensson M, Meyerson B, Linderoth B. Photochemically induced 
ischaemic lesion of the rat sciatic nerve. A novel method providing high incidence 
of mononeuropathy. Neuroreport 1996;7:2619-2623. 
Gear  RW,  Miaskowski  C,  Gordon  NC,  Paul SM, Heller PH, Levine JD. Kappa-
opioids produce  significantly greater  analgesia  in  women  than  in  men.  Nat 
Med 1996;2:1248-1250.  
Gear RW, Miaskowski C, Gordon NC, Paul SM, Heller PH, Levine JD. The kappa opioid  
nalbuphine  produces  gender-  and  dose-dependent  analgesia and  antianalgesia  in  
patients with  postoperative pain. Pain 1999;83:339-345. 
Godfrey L, Yan L, Clarke GD, Ledent C, Kitchen I, Hourani SM. Modulation of 
paracetamol antinociception by caffeine and by selective adenosine A2 receptor 
antagonists in mice. Eur J Pharmacol 2006;531:80-86. 
Gorman AL, Yu C-G, Ruenes GR, Daniels L, Yezierski RP. Conditions a�ecting the 
onset, severity, and progression of a spontaneous pain-like behavior after 
excitotoxic spinal cord injury. J Pain 2001;2:229–240.  
Greenspan JD, Craft RM, LeResche L, Arendt-Nielsen L, Berkley KJ, Fillingim RB, 
Gold MS, Holdcroft A, Lautenbacher S, Mayer EA, Mogil JS, Murphy AZ, Traub 
RJ; Consensus Working Group of the Sex, Gender, and Pain SIG of the IASP. 
Studying sex and gender differences in pain and analgesia: a consensus report. Pain 
2007;132:S26-45.  
Gruber CJ, Tschugguel W, Schneeberger C, Huber JC. Production and actions of 
estrogens. N Engl J Med  2002; 346:340–352. 
Halldner L, Aden U, Dahlberg V, Johansson B, Ledent C, Fredholm BB. The adenosine 
A(1) receptor contributes to the stimulatory, but not the inhibitory effect of caffeine 
on locomotion: a study in mice lacking adenosine A(1) and/or A(2A) receptors. 
Neuropharmacology 2004;46:1008–1017. 
Hao JX, Xu XJ, Aldskogius H, Seiger Å, Wiesenfeld-Hallin Z. Allodynia-like effect in rat 
after ischaemic spinal cord injury photochemically induced by laser irradiation. 
Pain 1991;45:175-185. 
Hao JX, Xu XJ, Yu YX, Aldskogius H, Seiger Å, Wiesenfeld-Hallin Z. Baclofen reverses 
the hypersensitivity of dorsal horn wide dynamic range neurons to low threshold 
mechanical stimuli after transient spinal cord ischemia: implication for a tonic 
GABAergic inhibitory control upon myelinated fiber input. J Neurophysiol 
1992;68:392-396.  
Hao JX, Blakeman KH, Yu W, Hultenby K, Xu XJ, Wiesenfeld-Hallin Z. Development 
of a mouse model of neuropathic pain following photochemically induced ischemia 
in the sciatic nerve. Exp Neurol 2000;163:231-238. 
Hao JX, Yu W, Xu XJ, Wiesenfled-Hallin Z.  Effects of intrathecal vs. systemic 
clonidine in treating chronic allodynia-like response in spinally injured rats. Brain 
Res 1996; 14: 736:28-34.  
Hogan Q. Animal pain models. Reginal Anesth and Pain Med 2002;27:385-401. 
   39 
Holdcroft A, Berkley KJ, Sex differences in pain and its relief. In: McMahon SB and 
Koltzenburg M (Eds.) Wall and Melzack’s Textbook of Pain, 5th edition. Elsevier, 
London, 2005, pp. 1181-1198. 
Horvath TL, Wikler KC. Aromatase in developing sensory systems of the rat brain. J 
Neuroendocrinol 1999;11:77-84. 
Hurley RW, Adams MC. Sex, gender, and pain: an overview of a complex field. Anesth 
Analg 2008;107:309-317. 
Hussey MJ, Clarke GD, Ledent C, Hourani SM, Kitchen I Reduced response to the 
formalin test and lowered spinal NMDA glutamate receptor binding in adenosine 
A2A receptor knockout mice. Pain 2007;129:287-294. 
Johansson B, Halldner L, Dunwiddie TV, Masino SA, Poelchen W, Gimenez-Llort L, 
Escorihuela RM, Fernandez-Teruel A, Wiesenfeld-Hallin Z, Xu XJ, Hardemark A, 
Betsholtz C, Herlenius E, Fredholm BB. Hyperalgesia, anxiety, and decreased 
hypoxic neuroprotection in mice lacking the adenosine A(1) receptor. Proc Natl 
Acad Sci USA 2001;98:9407-9412. 
Kaelin-Lang A, Lauterburg T, Burgunder JM. Expression of adenosine A2a receptor gene 
in rat dorsal root and autonomic ganglia. Neuroscience Letters 1998;246:21-24. 
Kandel ER, Schwartz JH. In: Kandel ER, Schwartz JH and Jessell TM (Eds.) Principles 
of Neural Science. Elsevier, New York, 1991, p. 388-310. 
Kelly MJ, Loose MD, Ronnekleiv OK, Estrogen suppresses mu-opioid- and GABAB-
mediated hyperpolarization of hypothalamic arcuate neurons. J Neurosci 
1992;12:2745-2750.  
Kest B, Sarton E, Dahan A. Gender differences in opioid-mediated analgesia: animal 
and human studies. Anesthesiology 2000;93(2):539-547.  
Kieffer BL, Gavériaux-Ruff C. Exploring the opioid system by gene knockout. Prog 
Neurobiol 2002;66:285–306.  
Kim SH, Chung JM. An experimental model for peripheral neuropathy produced by 
segmental spinal nerve ligation in the rat. Pain 1992;50:355-63. 
Koehler KF, Helguero LA, Haldosen LA,Warner M, and Gustafsson J A. Reflections on 
discovery and significance of estrogen receptor beta. Endocr 2005;26: 465-478. 
Krege JH, Hodgin JB, Couse JF, Enmark E,Warner M, Mahler JF, Sar M, Korach KS, 
Gustafsson JA, Smithies O. Generation and reproductive phenotypes of mice 
lacking estrogen receptor beta. Proc NatlAcad Sci USA 1998;95:15677–15682. 
Krinke GJ. Physiology of reproduction. In: Krinke GJ (Ed.) The laboratory rat. Academic 
Press, Switzerland, 2000, pp. 152-159. 
Krzanowska EK, Ogawa S, Pfaff DW, Bodnar RJ. Reversal of sex differences in 
morphine analgesia elicited from the ventrolateral periaqueductal gray in rats by 
neonatal hormone manipulations. Brain Res 2002;929:1-9. 
Kumar SP, Movahed A. Gender difference in the incidence of chest pain during 
adenosine pharmacologic stress testing. Cardiovas Res Rep 2002;23:317–318. 
 40 
Kupers R, Yu W, Persson JK, Xu XJ, Wiesenfeld-Hallin Z. Photochemically-induced 
ischemia of the rat sciatic nerve produces a dose-dependent and highly 
reproducible mechanical, heat and cold allodynia, and signs of spontaneous pain. 
Pain 1998;76:45-59.  
LaCroix-Fralish ML, Rutkowski MD, Weinstein JN, Mogil JS, Deleo JA. The magnitude 
of mechanical allodynia in a rodent model of lumbar radiculopathy is dependent on 
strain and sex. Spine 2005a;30:1821–1827. 
LaCroix-Fralish ML, Mogil JS. Progress in genetic studies of pain and analgesia. Annu 
Rev Pharmacol Toxicol 2009;49:97-121.  
LaCroix-Fralish ML, Tawfik VL, DeLeo JA. The organizational and activational effects 
of sex hormones on tactile and thermal hypersensitivity following lumbar nerve 
root injury in male and female rats. Pain 2005b;114:71-80. 
Lariviere, WR, Chesler, EJ,  Mogil, JS. Transgenic studies of pain and analgesia: 
mutation or background phenotype?  J Pharmacol Exp Ther 2001;297:467–473. 
Ledent C, Vaugeois JM, Schiffmann SN, Pedrazzini T, Yacoubi MEl, Vanderhaeghen JJ, 
Costentin J, Heath JK, Vassart G, Parmentier M. Aggressiveness, hypoalgesia and 
high blood pressure in mice lacking the adenosine A2a receptor. Nature 
1997;388:674-678. 
LeResche L, Mancl L, Sherman JJ, Gandara B, Dworkin SF. Changes in 
temporomandibular pain and other symptoms across the menstrual cycle. Pain 
2003;106:253–261. 
LeResche L, Saunders K, Von Korff MR, BarlowW, Dworkin SF. Use of exogenous 
hormones and risk of temporomandibular disorder pain. Pain 1997;69:153–160. 
Levin ER. Plasma membrane estrogen receptors. Trends Endocrinol Metab 
2009;20:477-482.  
Li J, Perl ER. Adenosine inhibition of synaptic transmission in the substantia gelatinosa. J 
Neurophysiol 1994;72:1611-1621. 
Light AR, Perl ER. Spinal termination of functionally  identified  primary  afferent  
neurons  with  slowly  conducting myelinated fibers. Journal of Comparative 
Neurology 1979;186:133-150. 
Linden J. Molecular approach to adenosine receptors: receptor-mediated mechanisms of 
tissue protection. Annu Rev Pharmacol Toxicol 2001;41:775-787. 
Lubahn DB, Moyer JS, Golding TS, Couse JF, Korach KS, Smithies O. Alteration of 
reproductive function but not prenatal sexual development after insertion disruption 
of the mouse estrogen receptor gene. Proc Natl Acad Sci USA 1993;90:11162-
11166. 
Malmber AB, Zeitz KP. Studies of pain mechanisms in genetically manipulated mice. In 
Mogil JS (Ed.) The genetics of pain, Progress in Pain research and treatment. IASP 
Press, Seattle, 2004, pp. 21-48. 
Mantyh PW, Clohisy DR, Koltzenburg M, Hunt SP. Molecular mechanisms of cancer 
pain. Nat Rev Cancer 2002;2:201-209.  
   41 
Marchand F, Perretti M, McMahon SB. Role of the immune system in chronic pain. Nat 
Rev Neurosci 2005;6:521-532.  
Marcondes FK, Bianchi GJ, Tanno, AP. Determination of estrous cycle phases of rats: 
Some helpful considerations. Braz J  Biol  2002;62;609-614. 
Marks HE, Hobbs, SH. Changes in stimulus reactivity following gonadectomy in male 
and female rats of different ages. Physiol Behav 1972;8:1113-1119. 
Martinez-Gomez M. Cruz Y, Salas M, Hudson R, Pacheco P. Assessing pain threshold in 
the rat: changes with estrus and time of day. Physiol Behav 1994;55:651-657. 
Martin VT, Lipton RB. Epidemiology and biology of menstrual migraine. Headache 
2008;48:S124–130. 
Martin D, Schoenen J, Delrée P, Gilson V, Rogister B, Leprince P, Stevenaert A, 
Moonen G. Experimental acute traumatic injury of the adult rat spinal cord by a 
subdural inflatable balloon: methodology, behavioral analysis, and histopathology. 
J Neurosci Res 1992;32:539-550.  
Merskey H, Bogduk N. Classification of Chronic pain. Descriptions of chronic pain 
Syndromes and Definitions of pain terms, 2nd Edition, 1994. 
Meyer, RA, Ringkamp, M, Campbell, JN, and Raja, SN.  Peripheral  mechanisms  of  
cutaneous  nociception. In: Wall PD, and Melzack R (Eds.) Textbook of Pain. 
Churchill Livingstone, London, 2008, pp.  3-29. 
Micevych PE, Eckersell CB, Brecha N, Holland KL. Estrogen modulation of opioid and 
cholecystokinin systems in the limbic-hypothalamic circuit. Brain Res Bull 
1997;44:335–343. 
Micevych P, Sinchak K. Estrogen and endogenous opioids regulate CCK in reproductive 
circuits. Peptides 2001;22:1235–1244. 
Mogil JS, McCarson KE. Identifying pain genes: bottom-up and top-down approaches. 
J Pain 2000;1:66-80. 
Mogil JS. Interaction between sex and genotype in the mediation and modulation of 
nociception in rodents. In: Filligham RB (Ed.). Sex, gender,and pain. IASP Press, 
Seattle, 2000, pp.  25–40. 
Mogil JS, Chesler EJ, Wilson SG, Juraska JM, Sternberg WF. Sex differences in 
thermal nociception and morphine antinociception in rodents depend on genotype. 
Neurosci Biobehav Rev 2000;24:375-389.  
Mogil JS, Wilson SG, Chesler EJ, Rankin AL, Nemmani KV, Lariviere WR, Groce MK, 
Wallace MR, Kaplan L, Staud R, Ness TJ, Glover TL, Stankova M, Mayorov A, 
Hruby VJ, Grisel JE, Fillingim RB. The melanocortin-1 receptor gene mediates 
female-specific mechanisms of analgesia in mice and humans. Proc Natl Acad Sci 
2003;15;100:4867-4872.  
Moulton EA, Keaser ML, Gullapalli RP, Maitra R, Greenspan JD. Sex differences in 
the cerebral BOLD signal response to painful heat stimuli. Am J Physiol Regul 
Integr Comp Physiol 2006;291:R257-267.  
 42 
Mueller SO, Korach KS. Estrogen receptors and endocrine diseases: lessons from 
estrogen receptor knockout mice. Curr Opin Pharmacol 2001;1:613-619.  
Murphy AZ, Ho�man GE. Distribution of gonadal steroid receptor-containing neurons in 
the preoptic-periaqueductal graybrainstem pathway: a potentia circuit for the 
initiation of male sexual behavior. J Comp Neurol 2001;438:191–212. 
Nelson LR, Bulun SE. Estrogen production and action. J Am Acad Dermatol 
2001;45:S116-124. 
Ness TJ, Gebhart GF. Colorectal distension as a noxious visceral stimulus: physiologic 
and pharmacologic characterization of pseudaffective reflexes in the rat. Brain 
Res 1988;450:153-169. 
Osterlund M, Kuiper GG, Gustafsson JA, Hurd YL. Differential distribution and 
regulation of estrogen receptor-alpha and –beta mRNA within the female rat brain. 
Mol Brain Res 1998;54:175–180. 
Pajot J, Ressot C, Ngom I, Woda A. Gonadectomy induces site-specific differences in 
nociception in rats. Pain 2003;104:367-373. 
Pamuk ON, Cakir N. The variation in chronic widespread pain and other symptoms in 
fibromyalgia patients. The effects of menses and menopause. Clin Exp Rheumatol 
2005;23:778-782. 
Paulson PE, Minoshima S, Morrow TJ, Casey KL. Gender differences in pain perception 
and patterns of cerebral activation during noxious heat stimulation in humans. Pain 
1998;76:223-229. 
Priest CA, Vink KL, Micevych PE. Temporal regulation by estrogen of beta-
preprotachykinin mRNA expression in the rat ventromedial nucleus of the 
hypothalamus. Brain Res Mol Brain Res 1995;28:61–71. 
Papka RE, Mowa CN. Estrogen receptors in the spinal cord, sensory ganglia, and pelvic 
autonomic ganglia. Int Rev Cytol 2003;231:91–127. 
Paller CJ, Campbell CM, Edwards RR, Dobs AS. Sex-based differences in pain 
perception and treatment. Pain Med 2009;10:289-299.  
Porreca F, Ossipov MH, Gebhart GF. Chronic pain and medullary descending 
facilitation. Trends Neurosci 2002;25:319-325.  
Poon A, Sawynok J. Antinociception by adenosine analogs and inhibitors of adenosine 
metabolism in an inflammatory thermal hyperalgesia model in the rat. Pain 
1998;74:235-245. 
Quiñones-Jenab V, Jenab S, Ogawa S, Inturrisi C, Pfaff DW. Estrogen regulation of 
mu-opioid receptor mRNA in the forebrain of female rats. Brain Res Mol Brain 
Res 1997;47:134-138. 
Reeve AJ, Dickenson AH. The roles of spinal adenosine receptors in the control of acute 
and more persistent nociceptive responses of dorsal horn neurons in the 
anesthetized rat. Br J of Pharmacol 1995;116:2221-2228.  
Ribeiro JA, Sebastião AM, de Mendonça A. Adenosine receptors in the nervous system: 
pathophysiological implications. Prog Neurobiol 2002;68:377-392. 
   43 
Riley JL 3rd, Robinson ME, Wise EA, Price DD. A meta-analytic review of pain 
perception across the menstrual cycle. Pain 1999;81:225-235. 
Robertson B, Xu XJ, Hao JX, Wiesenfeld-Hallin Z, Mhlanga J, Grant G, Kristensson K. 
Interferon-gamma receptors in nociceptive pathways: role in neuropathic pain-
related behaviour. Neuroreport 1997;8:1311–1316.  
Saleh TM, Connell BJ. Estrogen-induced autonomic effects are mediated by NMDA and 
GABAA receptors in the parabrachial nucleus. Brain Res 2003;973:161-170. 
Sawynok J. Adenosine receptor activation and nociception. Eur J Pharmacol 1998;347:1-
11. 
Sawynok J, Liu XJ. Adenosine in the spinal cord and periphery: release and regulation of 
pain. Prog Neurobiol 2003;69:313-340. 
Scholz J, Woolf CJ. Can we conquer pain? Nat Neurosci 2002;5:1062-1067. 
Schulte G, Robertson B, Fredholm BB, Delander GE, Shortland P, Molander C. 
Distribution of antinociceptive adenosine A1 receptors in the spinal cord dorsal 
horn, and relationship to primary afferents and neuronal subpopulations. 
Neuroscience 2003;121:907–916. 
Seltzer Z, Dubner R, Shir Y. A novel behavioral model of neuropathic pain disorders 
produced in rats by partial sciatic nerve injury. Pain 1990;43:205-218. 
Siddall P, Xu CL, Cousins M. Allodynia following traumatic spinal cord injury in the 
rat. Neuroreport 1995;19:1241-1244. 
Shughrue PJ, Lane MV, Merchenthaler I. Comparative distribution of estrogen receptor-
α and -β mRNA in the rat central nervous system. J Comp Neurol 1997;388:507-
525. 
Smeyne RJ, Klein R, Schnapp A. Severe sensory and sympathetic neuropathies in mice 
carrying a disrupted Trk/NGF receptor gene. Nature 1994;368:246-249. 
Spooner M-F, Robichaud P, Carrier JC, Marchand S. Endogenous pain modulation during 
the formalin test in estrogen receptor beta knockout mice. Neuroscience 
2007;150:675-680. 
Stoffel EC, Ulibarri CM, Craft RM. Gonadal steroid hormone modulation of 
nociception, morphine antinociception and reproductive indices in male and 
female rats. Pain 2003;103:285-302. 
Sugiura Y, Lee CL,  Perl E R. Central projections of identified, unmyelinated  (C)  
afferent  fibres  innervating mammalian skin. Science 1987;234:358–361. 
Taleghany N, Sarajari S, DonCarlos LL, Gollapudi L, Oblinger MM. Differential 
expression of estrogen receptor alpha and beta in rat dorsal root ganglion neurons. 
J Neurosci Res 1999;57:603-615. 
Tall JM, Crisp T, Effects of gender and gonadal hormones on nociceptive responses to 
intraplantar carrageenan in the rat, Neurosci Lett  2004;345:239–241. 
Tracey I. Nociceptive processing in the human brain. Curr Opin Neurobiol 
2005;15:478-487. 
 44 
von Euler M, Seiger A, Sundström E. Clip compression injury in the spinal cord: a 
correlative study of neurological and morphological alterations. Exp Neurol 
1997;145:502-510. 
Vincler M, Maixner W, Vierck CJ, Light AR. Estrous cycle modulation of nociceptive 
behaviors elicited by electrical stimulation and formalin. Pharmacol Biochem 
Behav 2001;69:315-324. 
Weiland NG. Glumate acid decraboxylase messenger ribonucleic acid is regulated by 
estradiol and progesterone in the hippocampus. Endocrinology 1992;131:2697-
2702. 
Wiesenfeld-Hallin Z. Sex differences in pain perception. Gend Med 2005;2:137-145.  
Woolf CJ. Pain: moving from symptom control toward mechanism-specific 
pharmacologic management; American College of Physicians; American 
Physiological Society. Ann Intern Med  2004;140:441-451. 
Wu WP, Hao JX, Halldner L, Lovdahl C, DeLander GE, Wiesenfeld-Hallin Z, Fredholm 
BB, Xu XJ. Increased nociceptive response in mice lacking the adenosine A1 
receptor. Pain 2005;113:395-404. 
Wu WP, Hao JX, Halldner-Henriksson L, Xu XJ, Jacobson MA, Wiesenfeld-Hallin Z, 
Fredholm BB. Decreased inammatory pain due to reduced carrageenan-induced 
inammation in mice lacking adenosine A3 receptors. Neuroscience 2002;14:523–
527. 
Xu, XJ, Hao, JX, Andell-Jonsson, S. Nociceptive responses in interleukin-6-decient 
mice to peripheral inammation and peripheral nerve section. Cytokine 
1997;9:1028–1033. 
Xu XJ and Wiesenfeld-Hallin Z. Applied physiology of neuropathic pain: experimental 
models and their application in the study of mechanisms and treatment. In: Rice 
ASC, Warfield CA, Justins D, Eccleston C (Eds.). Clinical Pain management, 
Chronic pain.  Arnold, London,  2003, pp. 113-124. 
Xu XJ, Hao JX, Aldskogius H, Seiger A, Wiesenfeld-Hallin Z. Chronic pain-related 
syndrome in rats after ischemic spinal cord lesion: a possible animal model for 
pain in patients with spinal cord injury. Pain 1992;48:279-290.  
Zubieta JK, Smith  YR,  Bueller JA, Xu Y, Kilbourn MR, Jewett DM, Meyer CR, 
Koeppe RA, Stohler CS. Mu-opioid receptor-mediated  antinociceptive  responses  
differ in men and women. J Neurosci 2002;22:5100-5107. 
Zhang AL, Hao JX, Seiger Å, Xu X-, Wiesenfeld-Hallin Z, Grant G, Aldskogius H. 
Decreased GABA immunoreactivity in spinal cord dorsal horn neurons after 
transient spinal cord ischemia in the rat. Brain Res 1994;656:187-190.  
Yang JN, Tiselius C, Dare E, Johansson B, Valen G, Fredholm BB. Sex differences in 
mouse heart rate and body temperature and in their regulation by adenosine A1 
receptors. Acta Physiol 2007;190:63–75. 
Yoon MH, Bae HB, Choi JI. Antinociception of intrathecal adenosine receptor subtype 
agonists in rat formalin test. Anesth Analg 2005;101:1417-1421.  
 
